Investors interested in stocks from the REIT and Equity Trust - Other sector have probably already heard of American Tower (AMT - Free Report) and Public Storage (PSA - Free Report) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.
American Tower and Public Storage are sporting Zacks Ranks of #2 (Buy) and #3 (Hold), respectively, right now. The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that AMT has an improving earnings outlook. But this is just one factor that value investors are interested in.
Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.
The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors.
AMT currently has a forward P/E ratio of 17.10, while PSA has a forward P/E of 19.23. We also note that AMT has a PEG ratio of 0.76. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. PSA currently has a PEG ratio of 4.43.
Another notable valuation metric for AMT is its P/B ratio of 8.59. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, PSA has a P/B of 11.51.
Based on these metrics and many more, AMT holds a Value grade of B, while PSA has a Value grade of D.
AMT stands above PSA thanks to its solid earnings outlook, and based on these valuation figures, we also feel that AMT is the superior value option right now.
CrowdStrike replaces static policies and standing privileges with continuous, risk-aware enforcement, authorizing every agent action based on who owns it, who is calling it, and real-time risk
AUSTIN, Texas & LAS VEGAS--(BUSINESS WIRE)--Identiverse 2026 – CrowdStrike (NASDAQ: CRWD) today announced Continuous Identity for AI Agents, a new CrowdStrike Falcon® Next-Gen Identity Security capability that reinforces the CrowdStrike Falcon® platform as the identity security control plane for the agentic enterprise.
As AI agents operate with superhuman speed and access, legacy models built on static policies and standing privileges break down – granting access without context, blind to real-time risk. CrowdStrike delivers a fundamentally different model: every agent action continuously authorized in real time based on who owns the agent, who is calling it, and the risk posture of their device – evaluated against native and third-party risk signals on the Falcon platform.
“AI agents are transforming how work gets done, and how identities must be secured,” said Elia Zaitsev, chief technology officer, CrowdStrike. “Point-in-time authorization becomes a legacy approach the second agents are given autonomy. Authorize once and trust indefinitely is not a security model; it's a liability. That's the shift CrowdStrike is driving, from static, one-time access decisions to Continuous Identity.”
Securing AI Agent Identities
AI agents invoke tools, access sensitive data, call APIs, and delegate to sub-agents at machine speed with system-level privilege. Legacy access models were never built to control this. Continuous Identity for AI Agents – powered by technology from CrowdStrike's recent acquisition of SGNL – dynamically grants, denies, and revokes access based on real-time risk, eliminating standing privileges entirely.
Verifiable Agent Identity: Every agent is assigned a cryptographically verifiable identity based on the SPIFFE standard, an open standard that replaces static credentials like API keys with automated, secure workload identities. Context-Aware Authorization: Access is evaluated based on who owns the agent, who is calling it, and the risk posture of their device. When an agent delegates to a sub-agent, that context is preserved throughout the chain. Zero Standing Privilege: Access is granted the moment it’s needed and revoked the moment it’s not. Defense in Depth: Continuous Identity ensures agents operate with only the privileges they need. Falcon® AI Detection and Response (AIDR) continuously inspects prompts and intent to detect permission misuse or attempts to manipulate an LLM beyond its authorized scope, triggering Continuous Identity to revoke access before damage is done. Continuous Identity for AI Agents extends CrowdStrike’s risk-aware authorization across every identity – human, non-human, and AI agent – from initial access to privilege escalation and lateral movement spanning on-prem, SaaS, browser, and cloud environments.
To learn more about how CrowdStrike is transforming identity security for the agentic era, read our blog and visit here.
Forward-Looking Statements
This press release may include discussion of unreleased services or features. Any unreleased services or features referenced here are still in development and subject to change. Customers should make their purchase decisions based upon features that are currently available.
About CrowdStrike
CrowdStrike (NASDAQ: CRWD), a global cybersecurity leader, has redefined modern security with the world’s most advanced cloud-native platform for protecting critical areas of enterprise risk – endpoints and cloud workloads, identity and data.
Powered by the CrowdStrike Security Cloud and world-class AI, the CrowdStrike Falcon® platform leverages real-time indicators of attack, threat intelligence, evolving adversary tradecraft and enriched telemetry from across the enterprise to deliver hyper-accurate detections, automated protection and remediation, elite threat hunting and prioritized observability of vulnerabilities.
Purpose-built in the cloud with a single lightweight-agent architecture, the Falcon platform delivers rapid and scalable deployment, superior protection and performance, reduced complexity and immediate time-to-value.
CrowdStrike: We stop breaches.
Learn more: https://www.crowdstrike.com/
Follow us: Blog | X | LinkedIn | Instagram
Start a free trial today: https://www.crowdstrike.com/trial
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.
By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.
However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.
NetEase (NTES - Free Report) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.
Research shows that stocks carrying the best growth features consistently beat the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy).
Here are three of the most important factors that make the stock of this internet technology company a great growth pick right now.
Earnings GrowthArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for NetEase is 22.3%, investors should actually focus on the projected growth. The company's EPS is expected to grow 14.2% this year, crushing the industry average, which calls for EPS growth of 12.8%.
Cash Flow GrowthWhile cash is the lifeblood of any business, higher-than-average cash flow growth is more important and beneficial for growth-oriented companies than for mature companies. That's because, growth in cash flow enables these companies to expand their businesses without depending on expensive outside funds.
Right now, year-over-year cash flow growth for NetEase is 17%, which is higher than many of its peers. In fact, the rate compares to the industry average of 8.3%.
While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 16.7% over the past 3-5 years versus the industry average of 15.9%.
Promising Earnings Estimate RevisionsBeyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
There have been upward revisions in current-year earnings estimates for NetEase. The Zacks Consensus Estimate for the current year has surged 7.3% over the past month.
Bottom LineWhile the overall earnings estimate revisions have made NetEase a Zacks Rank #2 stock, it has earned itself a Growth Score of B based on a number of factors, including the ones discussed above.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination positions NetEase well for outperformance, so growth investors may want to bet on it.
Key Takeaways QIAGEN expanded its QIAcuity dPCR ecosystem with gene expression tools and automation.New QIAcuity assays and a multiplex PCR kit aim to reduce sample use and workflow complexity.QIAcuity has topped 3,200 placements worldwide and is cited in over 1,100 publications. QIAGEN (QGEN - Free Report) recently expanded its QIAcuity digital PCR (dPCR) ecosystem with new gene expression solutions, enhanced multiplexing capabilities, workflow automation and standardized analysis tools. The move is aimed at accelerating the adoption of dPCR across research and biopharma applications as customers increasingly seek higher sensitivity, precision and scalability beyond traditional qPCR technologies.
From an investor's perspective, the latest additions strengthen QIAGEN's position in the fast-growing digital PCR market and expand its reach into gene expression, one of molecular biology's largest application areas. The broader QIAcuity portfolio, combined with automation and cell and gene therapy capabilities, could support higher platform adoption and create new long-term growth opportunities for the company.
Likely Trend of QGEN Stock Following the NewsShares of QGEN have traded flat since the announcement of the news. In the year-to-date period, shares of the company have lost 21.7% compared with the industry’s 1.3% decline. The S&P 500 increased 8.1% in the same time frame.
The expansion of the QIAcuity ecosystem is expected to strengthen QIAGEN's long-term growth prospects by broadening the platform's applications across gene expression research, cell and gene therapy quality control and high-throughput biopharma workflows. The launch of new assays, enhanced multiplexing capabilities and workflow automation should drive higher instrument placements, increase recurring consumables demand and deepen customer engagement. As more laboratories transition from qPCR to dPCR technologies, QIAGEN is well-positioned to capture a larger share of the expanding digital PCR market and build a more durable, recurring revenue stream around the QIAcuity franchise.
QGEN currently has a market capitalization of $7.64 billion.
Image Source: Zacks Investment Research
More on the NewsAs part of the expansion, QIAGEN plans to launch new QIAcuity Gene Expression Assays later in 2026 to support gene expression analysis across human, mouse and rat research applications. The company also intends to introduce the QIAcuity OneStep High Multiplex Probe PCR Kit, which can analyze up to 12 RNA targets in a single reaction. The offering is expected to help researchers generate richer biological insights while reducing sample consumption, hands-on time and workflow complexity. These solutions complement QIAGEN's GeneGlobe platform, which provides access to more than 10 million predesigned assays and custom assay design capabilities.
QIAGEN is also broadening its Cell and Gene Therapy quality-control portfolio by expanding its residual DNA testing offerings to support additional producer cell systems, including Sf9/Baculovirus, Pichia pastoris, Vero and Mouse. The portfolio further includes the recently launched QIAcuity HEK293 resDNA Sizing Kit, which enables precise measurement of host-cell DNA concentration and fragment size distribution, supporting biopharmaceutical development and manufacturing workflows.
Further, QIAGEN plans to release QIAcuity Software 3.5 later this month, introducing advanced analysis templates and automated reporting capabilities that allow laboratories to define analysis and reporting parameters before a run begins. By automatically applying analysis parameters and generating reports after run completion, the software is expected to improve traceability, consistency and operational efficiency, particularly in larger-scale and regulated environments.
Additionally, through its collaboration with Hamilton, QIAGEN is enabling automated QIAcuity dPCR nanoplate setup and handling workflows, spanning sample preparation, nanoplate filling and sealing. The company noted that QIAcuity has achieved more than 3,200 cumulative placements worldwide, with over 400 customers operating multiple instruments and more than 1,100 scientific publications referencing the platform.
Favorable Industry Prospect for QGENPer a report by Precedence Research, the global digital PCR market size was $7.78 billion in 2025 and is predicted to increase from $8.51 billion in 2026 to approximately $18.72 billion by 2035, expanding at a CAGR of 9.18%.
The market is driven by increasing demand for accurate and reliable nucleic acid testing in areas such as clinical diagnostics, research and development and biopharmaceuticals.
A Recent Development by QGENRecently, QIAGEN announced that its QIAstat-Dx Meningitis/Encephalitis Panel has been included in the Australian Register of Therapeutic Goods, expanding the company's molecular diagnostic offerings in Australia. The panel enables the detection of 16 common bacterial, viral and fungal pathogens, including cytomegalovirus and Streptococcus pyogenes, from a single cerebrospinal fluid sample using multiplex PCR technology. Delivering results in about one hour, the test supports rapid and accurate clinical decision-making in acute care settings and becomes the third QIAstat-Dx panel registered in Australia, alongside respiratory and gastrointestinal infection testing solutions.
Some better-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , West Pharmaceutical (WST - Free Report) and Intuitive Surgical (ISRG - Free Report) .
Globus Medical, currently flaunting a Zacks Rank #1 (Strong Buy), reported a first-quarter 2026 adjusted earnings per share (EPS) of $1.12 per share, which surpassed the Zacks Consensus Estimate by 22.1%. Revenues of $759.9 million beat the Zacks Consensus Estimate by 4.0%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GMED has an estimated long-term earnings growth rate of 10.2% compared with the industry’s 12.6% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 26.3%.
West Pharmaceutical, currently sporting a Zacks Rank #1, reported first-quarter 2026 EPS of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%.
WST has an estimated long-term earnings growth rate of 13.9% compared with the industry’s 9.5% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 19.4%.
Intuitive Surgical, carrying a Zacks Rank #2 (Buy) at present, reported first-quarter 2026 adjusted EPS of $2.50, which beat the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%.
ISRG has a long-term estimated growth rate of 14.6% compared with the industry’s 12.6% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.
Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction) stock is up 5% in Monday midday trading, changing hands near $134. The move comes alongside a broad risk-on rally, with the NASDAQ 100 tracking ETF Invesco QQQ Trust (NASDAQ:QQQ) up 3% on the session.
Cloudflare (NYSE:NET) stock is following the same script, trading higher by 3% to around $235 and change. There’s no identified company-specific catalyst for either name today, which makes the parallel moves notable.
Investors appear to be rotating back into AI and security software exposure as risk appetite returns. The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is up 1.9% intraday, confirming the breadth of the bid.
Risk-On Rally Lifts AI and Security Software The catalyst is macro-related, not company-specific. A U.S.-Iran peace deal announced Sunday has lifted equities, pushing major indexes back toward highs and reviving appetite for higher-beta growth names.
Palantir fits that profile cleanly. Palantir stock carries a beta of 1.5 and a forward P/E ratio of 88x, and it tends to amplify directional moves in the broader market. Cloudflare stock is even more sensitive, with a beta of 1.7 and a forward P/E ratio of 189x.
Both names sit in the AI infrastructure and security segment. Palantir’s AIP platform powers government and commercial AI deployments, while Cloudflare provides the edge-network and zero-trust security layer that increasingly carries agentic AI traffic. When investors reach for AI and security software exposure, these two are first-call tickers.
Context: A Bounce Inside a Down Year Today’s pop in Palantir shares lands inside a tough year. PLTR stock is down 24% year to date (YTD) and trades well below its 200-day moving average of $160.42. Still, the company’s fundamentals remain strong, with 85% year-over-year (YoY) revenue growth in Q1 2026, but the valuation has been the sticking point.
Cloudflare has traveled a different path. NET stock is up 20% YTD, helped by the company’s pivot to an agentic AI-first operating model and a $42.5 million annual contract value deal disclosed alongside Cloudflare’s Q4 2025 results.
CEO Matthew Prince has framed the opportunity bluntly, declaring that “AI is driving a fundamental re-platforming of the Internet… it’s shaping up to be the biggest tailwind we’ve ever seen in Cloudflare’s history.” That narrative is doing some of the work on days like today.
What to Watch Now Both stocks are speculative, high-volatility names that can give back gains as quickly as they take them. Wall Street’s average price target sits at $183.73 for Palantir and $243.11 for Cloudflare, suggesting analysts already see fair value not far from current levels.
Investors can watch for whether today’s gains hold into the close and whether QQQ and SPY maintain their intraday strength. If the macro bid fades, beta names like these tend to lead the retracement on the way down.
Investors looking for stocks in the Textile - Apparel sector might want to consider either Superior Group (SGC - Free Report) or Cintas (CTAS - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.
Right now, Superior Group is sporting a Zacks Rank of #2 (Buy), while Cintas has a Zacks Rank of #3 (Hold). This system places an emphasis on companies that have seen positive earnings estimate revisions, so investors should feel comfortable knowing that SGC is likely seeing its earnings outlook improve to a greater extent. However, value investors will care about much more than just this.
Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.
The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors.
SGC currently has a forward P/E ratio of 23.66, while CTAS has a forward P/E of 32.55. We also note that SGC has a PEG ratio of 2.37. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. CTAS currently has a PEG ratio of 2.80.
Another notable valuation metric for SGC is its P/B ratio of 1.13. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, CTAS has a P/B of 14.72.
These are just a few of the metrics contributing to SGC's Value grade of B and CTAS's Value grade of F.
SGC stands above CTAS thanks to its solid earnings outlook, and based on these valuation figures, we also feel that SGC is the superior value option right now.
Appointment reinforces the firm's focus on client engagement, growth, and global reach
, /PRNewswire/ -- T. Rowe Price (NASDAQ: TROW) today announced that Mike Barry has been named head of Global Marketing, effective July 1. Mr. Barry will report to Dee Sawyer, head of Global Distribution.
Mr. Barry becomes head of Global Marketing as T. Rowe Price continues to build on its long-standing commitment to helping clients achieve their financial goals through investment excellence, deep research, and client-focused innovation. His organization will lead marketing efforts to connect clients worldwide with the firm's insights, solutions, and capabilities across retail, wealth, retirement, and institutional markets. Additionally, he will oversee brand strategy and development, public relations, global digital solutions, investment and retirement content, along with global product and segment marketing.
Mr. Barry has more than 20 years of experience at T. Rowe Price. Most recently, he served as head of Global Product Marketing and Investment, Product, and Retirement Content, where he expanded the reach of the firm's market perspectives and investment insights. In 2024, he oversaw the launch of T. Rowe Price's marketing innovation lab, bringing together marketing associates from around the world to explore how digital and AI-enabled technologies could strengthen the firm's capabilities. That work led to new translation, design, and personalization capabilities now leveraged by the firm.
QUOTES
Dee Sawyer, Head of Global Distribution
"Mike brings a rare combination of investment fluency, strategic perspective, and client focus to this role. He has helped strengthen how T. Rowe Price translates investment insights into relevant solutions and meaningful client engagement across markets and channels. As head of Global Marketing, Mike will play an important role in advancing our growth strategy and deepening how we serve clients worldwide."
Mike Barry, Head of Global Marketing
"T. Rowe Price has earned clients' trust through investment excellence, deep research, and a strong commitment to helping investors achieve their goals. As client needs evolve, we have an opportunity to make our insights, solutions, and expertise even more accessible. I'm excited to work with our teams around the world to strengthen how we serve clients and bring the best of T. Rowe Price to market."
ABOUT MIKE BARRY
Mike Barry is a Vice President of T. Rowe Price Group, Inc., and a member of the Global Marketing Leadership Team. Since 2005, his work has aligned marketing strategy to commercial priorities, strengthened global brand positioning, and driven innovation through digital and AI-enabled capabilities. He also serves on executive steering committees focused on thought leadership, private markets, and enterprise workflow transformation, and was instrumental in the launch of the T. Rowe Price Investment Institute and The Angle podcast.
ABOUT T. ROWE PRICE
T. Rowe Price (NASDAQ-GS: TROW) is a leading global asset management firm, entrusted with managing $1.89 trillion in client assets as of May 31, 2026, about two-thirds of which are retirement-related. Renowned for over 85 years of investment excellence, retirement leadership, and independent proprietary research, the firm leverages its longstanding expertise to ask better questions that can drive better investment decisions. Built on a culture of integrity and prioritizing client interests, T. Rowe Price empowers millions of investors worldwide to thrive amid evolving markets. Visit troweprice.com/newsroom for news and public policy commentary.
View original content to download multimedia:https://www.prnewswire.com/news-releases/t-rowe-price-names-mike-barry-as-head-of-global-marketing-302800439.html
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lucid Group To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Lucid Group between February 25, 2026 and April 13, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - June 15, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lucid Group, Inc. ("Lucid Group" or the "Company") (NASDAQ: LCID) and reminds investors of the July 28, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) a supplier quality issue had significantly disrupted deliveries of the Lucid Gravity; (2) the foregoing was likely to, and did, have a material negative impact on the Company's business and financial results; (3) accordingly, the Defendants had overstated the purported enhancements to Lucid's manufacturing and delivery capabilities and overall operations; and (4) as a result, Defendants' public statements were materially false and misleading at all relevant times.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Lucid Group's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Lucid Group class action, go to www.faruqilaw.com/LCID or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the Lucid Group, Inc. Securities Class Action Lawsuit:
What is the Lucid Group securities fraud lawsuit about?
The Lucid Group securities fraud lawsuit is a federal securities class action alleging that Lucid Group, Inc. (NASDAQ: LCID) and its executives made false and misleading statements to investors by concealing that a supplier quality issue had significantly disrupted deliveries of the Lucid Gravity SUV and overstating the Company's manufacturing and delivery capabilities. As the truth emerged through a series of disclosures - including an April 3, 2026 announcement that only 3,093 vehicles were delivered in Q1 2026 due to a 29-day delivery disruption caused by a supplier seat defect, an April 14, 2026 filing revealing Q1 revenue of just $280-$284 million against a consensus estimate of $433.8 million and a $1.05 billion capital raise, and a May 5, 2026 earnings report showing a net loss of over $1 billion and GAAP EPS of -$3.46 - LCID's stock price fell sharply across multiple trading sessions, causing significant losses for investors.
Who may be eligible to participate in the Lucid Group class action lawsuit?
Investors who purchased or acquired Lucid Group, Inc. (LCID) stock between February 25, 2026 and April 13, 2026 - the Class Period - and suffered financial losses may be eligible to participate in the Lucid Group securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former Lucid Group employees, and others with relevant information about the Company's conduct are also encouraged to come forward.
What is a lead plaintiff, and how can I seek appointment in the Lucid Group lawsuit?
A lead plaintiff in the Lucid Group class action is a court-appointed investor - typically the one with the largest financial interest in the case - who directs and oversees the litigation on behalf of all class members. Any Lucid Group investor who purchased LCID stock during the Class Period may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is July 28, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.
What should investors do if they purchased Lucid Group stock during the Class Period?
Investors who purchased Lucid Group, Inc. (LCID) stock between February 25, 2026 and April 13, 2026 and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the Lucid Group securities class action is July 28, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/LCID for more information.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301506
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Meetings with Upstart Holdings Inc's (NASDAQ:UPST) top management suggests that the company is focusing on near-prime personal loans, AI-led product development and underwriting, according to Needham.
The Upstart Holdings Analyst: Analyst Kyle Peterson reaffirmed a Buy rating and price target of $37.
The Upstart Holdings Thesis: The company's current focus "is the right tonic to get the stock back on track," Peterson said in the note.
Check out other analyst stock ratings.
Upstart Holdings has set an ambitious target of generating revenues at a 35% CAGR (compounded annual growth rate) from fiscal 2025 through 2028, the analyst stated. The company could "lean heavily" into areas where its AI-based underwriting model excels, such as near-prime personal loans, he added.
Upstart Holdings is likely to try and supplement core personal loan growth with growth in other asset classes that align with its customer base, Peterson noted. "The newly announced Cash Line product is the most logical step in our view and UPST’s answer to earned wage access products that many neobanks are having strong success with of late," he wrote.
Other areas that the company may target include HELOCs (home equity lines of credit) and auto loans, the analyst stated. "While these products are relatively small today, we believe the underwriting models are fine-tuned and that growth can be unleashed quickly as funding falls into place,' he further wrote.
Margin Saga: The recent stock performance has been range-bound, after Upstart Holdings' 2026 EBITDA margin outlook reflected a contraction of 100 basis points (bps), Peterson said.
While stating that 2026 could be a transition year for margins, the analyst added that Upstart Holdings' new investment strategy and further AI improvements could bring "quick pay-back periods" and allow the company to reach or exceed its medium-term financial targets.
UPST Price Action: Shares of Upstart Holdings had risen by 9.20% to $33.30 at the time of publication on Monday.
Photo: JHVEPhoto / Shutterstock
Market News and Data brought to you by Benzinga APIs
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.
In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.
However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.
Our proprietary system currently recommends Lam Research (LRCX - Free Report) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank.
Studies have shown that stocks with the best growth features consistently outperform the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.
While there are numerous reasons why the stock of this semiconductor equipment maker is a great growth pick right now, we have highlighted three of the most important factors below:
Earnings GrowthEarnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for Lam Research is 8.5%, investors should actually focus on the projected growth. The company's EPS is expected to grow 37.6% this year, crushing the industry average, which calls for EPS growth of 34.9%.
Cash Flow GrowthCash is the lifeblood of any business, but higher-than-average cash flow growth is more beneficial and important for growth-oriented companies than for mature companies. That's because, high cash accumulation enables these companies to undertake new projects without raising expensive outside funds.
Right now, year-over-year cash flow growth for Lam Research is 31.2%, which is higher than many of its peers. In fact, the rate compares to the industry average of 1.5%.
While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 16.6% over the past 3-5 years versus the industry average of 5.9%.
Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
There have been upward revisions in current-year earnings estimates for Lam Research. The Zacks Consensus Estimate for the current year has surged 0.5% over the past month.
Bottom LineWhile the overall earnings estimate revisions have made Lam Research a Zacks Rank #2 stock, it has earned itself a Growth Score of B based on a number of factors, including the ones discussed above.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination indicates that Lam Research is a potential outperformer and a solid choice for growth investors.
Key Takeaways CSX trades at a higher forward P/E ratio than its industry average, signaling an expensive valuation.During 2025, CSX repurchased shares worth $1.39 billion and paid $972 million in dividends.For 2026, CSX now expects mid-single digit revenue growth (prior view: low single-digit revenue growth). CSX Corporation (CSX - Free Report) looks expensive from a valuation standpoint. Considering the forward 12-month price-to-sales ratio (P/E-F12M), CSX is trading at a premium compared to the industry.
The stock has a forward 12-month P/E-F12M of 23.63X compared with 21.95X for the industry over the past five years. The company’s forward 12-month P/E-F12M ratio is also above the median level of 17.35X over the past five years. These factors indicate that the stock’s valuation is unattractive. CSX has a Value Score of D.
CSX P/E Ratio (Forward 12 Months) Vs. Industry Image Source: Zacks Investment Research
Now, the question is whether it is worth buying, holding, or selling the CSX stock at current prices. Let us delve deeper to find out.
Factors Working in Favor of CSX StockCSX's focus on improving workplace safety for employees is also commendable. As a reflection of this, the Federal Railroad Administration's (FRA) Personal Injury Frequency Index, a measure of the number of FRA-reportable injuries per 200,000 man-hours, improved to 0.94 in 2025 from 1.23 in 2024. The FRA train accident rate improved to 3.08 in 2025 from 3.56 in 2024.
Meanwhile, CSX has been consistently making efforts to strengthen its relations with its employees. To this end, the railroad company has entered into multi-year collective bargaining agreements with the Brotherhood of Railroad Signalmen and the International Brotherhood of Boilermakers, Iron Ship Builders, Forgers & Helpers; the Brotherhood of Locomotive Engineers and Trainmen in 2025 for the well-being of its employees. CSX is currently engaged in bargaining with SMART-TD to consolidate separate territories, workforces and execute a single-system collective agreement. Such deals reflect the employee-friendly attitude of CSX, through which it strives to maintain cordial relations with its employees and the unions representing them, thereby providing a healthy work environment at CSX.
Additionally, CSX has been consistently making efforts to reward its shareholders through dividends and share buybacks, which are encouraging. Continuing the shareholder-friendly approach, CSX rewarded its shareholders in 2022 through a combination of cash dividends ($852 million) and share repurchases ($4.73 billion). During 2023, CSX repurchased shares worth $3.48 billion and paid $882 million in cash dividends. During 2024, CSX repurchased shares worth $2.23 billion and paid $930 million in cash dividends. During 2025, CSX repurchased shares worth $1.39 billion and paid $972 million in the form of dividend payments. During first-quarter 2026, CSX repurchased shares worth $222 million and paid $260 million in the form of dividend payments. Such shareholder-friendly initiatives should boost investor confidence and positively impact the bottom line.
CSX Stock’s Price PerformanceShares of CSX have gained 31.3% so far this year, outperforming the Zacks Transportation - Rail industry’s 20% surge, as well as that of other industry players, Norfolk Southern Corporation (NSC - Free Report) and Canadian National Railway Company (CNI - Free Report) ), within the same time frame.
CSX Stock’s YTD Price Comparison Image Source: Zacks Investment Research
What Do Earnings Estimates Say for CSX?The positive sentiment surrounding CSX stock is evident from the fact that the Zacks Consensus Estimate for the second-quarter 2026 as well as third-quarter of 2026 earnings, has been revised upward in the past 60 days. The consensus mark for full year 2026 and 2027 earnings has also been projected northward in the past 60 days.
Image Source: Zacks Investment Research
The favorable estimate revisions indicate brokers’ confidence in the stock.
Time to Buy CSX StockCSX’s focus on improving workplace safety for employees is also commendable. Meanwhile, CSX has been consistently making efforts to strengthen its relations with its employees through the multi-year collective bargaining agreements with the unions (representing the employees). The company’s consistent efforts to continue rewarding its shareholders by paying dividends and buying back shares look appreciative.
We believe that the positives surrounding the stock (as highlighted throughout the write-up) outweigh the concerns regarding high debt load, weak coal market, supply chain disturbances, network-related issues and share price volatility coupled with unattractive valuation. We, therefore, suggest investors add CSX stock to their portfolios for healthy returns. The company’s Zacks Rank #2 (Buy) further supports our thesis. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
CSX (CSX - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.
The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.
As such, the Zacks rating upgrade for CSX is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
For CSX, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.
Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for CSXThis freight railroad is expected to earn $1.90 per share for the fiscal year ending December 2026, which represents no year-over-year change.
Analysts have been steadily raising their estimates for CSX. Over the past three months, the Zacks Consensus Estimate for the company has increased 2.9%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of CSX to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/ZTS.
Zoetis Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements concerning the growth, competitive positioning, market share, and veterinarian adoption of key products within the Companion Animal segment while failing to disclose that:
(1) veterinarian prescription growth and adoption of Zoetis’ Librela, a canine pain treatment, were sharply weakening as clinicians became more cautious following FDA safety warnings concerning serious neurological complications in dogs;
(2) Zoetis’ Simparica Trio was losing significant market share to a lower-priced competing canine parasiticide with broader indicated use in a slowing overall market; and
(3) Zoetis’ dermatology products, Apoquel and Cytopoint, were losing substantial market share to a newly launched competing canine treatment.
What's Next for Zoetis Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/ZTS. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Zoetis you have until July 27, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to Zoetis Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Zoetis Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
LOS ANGELES, June 15, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 27, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) securities between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”).
IF YOU SUFFERED A LOSS ON YOUR ZOETIS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.
What Happened?
On August 5, 2025, Zoetis released its second quarter 2025 financial results, reporting weakened demand trends within its Companion Animal portfolio.
On this news, Zoetis’ stock price fell $5.69, or 3.8%, to close at $146.12 per share on August 5, 2025, thereby injuring investors.
Then, on November 4, 2025, Zoetis released its third quarter 2025 financial results, revealing slowed growth across its key Companion Animal franchises and disclosing continued weakness in sales of its canine pain treatment, Librela, and increased competitive pressure in dermatology and parasiticides. The Company also lowered its full year sales outlook.
On this news, Zoetis’ stock price fell $19.89, or 13.8%, to close at $124.46 per share on November 4, 2025.
Then, on May 7, 2026, Zoetis released its first quarter 2026 financial results, reporting slowing overall revenue growth, declining Companion Animal sales performance, and worsening results across its key dermatology and parasiticides franchises, stating that “competition intensified across key pet care categories, including dermatology and parasiticides,” that “pet owners demonstrated increased price sensitivity,” and that “these new entrants have not yet translated into overall market expansion.”
The Company also explained that “price has played a larger role in the decision process,” that “[s]hare loss is being amplified by a derm market with declining patient volume in the clinic,” and that contraction in the parasiticides market was negatively impacting prescription volumes and compliance. In addition, the Company admitted that it was operating in “a more price sensitive and competitive environment” and further reduced its 2026 growth outlook based on continuing competitive and operating pressures.
On this news, Zoetis’ stock price fell $23.91, or 21.5%, to close at $87.31 per share on May 7, 2026, thereby injuring investors further.
What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) veterinarian prescription growth and adoption of Zoetis’ Librela, a canine pain treatment, were sharply weakening as clinicians became more cautious following FDA safety warnings concerning serious neurological complications in dogs; (2) Zoetis’ Simparica Trio was losing significant market share to a lower priced competing canine parasiticide with broader indicated use in a slowing overall market; and (3) Zoetis’ dermatology products, Apoquel and Cytopoint, were losing substantial market share to a newly launched competing canine treatment; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you purchased or otherwise acquired Zoetis securities during the Class Period, you may move the Court no later than July 27, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.
Investors might want to bet on Ross Stores (ROST - Free Report) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.
Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.
As such, the Zacks rating upgrade for Ross Stores is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Ross Stores imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for Ross StoresThis discount retailer is expected to earn $7.74 per share for the fiscal year ending January 2027, which represents no year-over-year change.
Analysts have been steadily raising their estimates for Ross Stores. Over the past three months, the Zacks Consensus Estimate for the company has increased 7.5%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Ross Stores to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Stocks are rallying to kick off the week, after President Donald Trump announced a peace deal between the U.S. and Iran, as well as the reopening of the Strait of Hormuz, sending oil prices lower. Both the Dow Jones Industrial Average (DJI) and Nasdaq Composite Index (IXIC) are up over 600 points, with the former notching a fresh record high, while the S&P 500 Index (SPX) enjoys a rare triple-digit gain.
Meanwhile, The New York Fed’s Empire State Manufacturing Index fell to 5.7 in June, down nearly 14 points from May and missing expectations of 13.9. Builder sentiment remained weak, per the NAHB Housing Market index, which fell two points to 35 in June.
Continue reading for more on today's market, including:
Micron stock surges on AI-fueled bull notes. Why Fox stock is headed for worst day ever. Plus, options traders target ROKU; WDC hits record highs; and FISV slips on CEO departure.
Options traders are eyeing Roku Inc (NASDAQ:ROKU) today, after news that Fox is acquiring the streaming name for $22 billion. So far, 25,000 calls and 11,000 puts have been exchanged, which is five times the stock's average daily options volume. The June 150 and 125 call contracts are the most popular, with new positions being sold-to-open at the June 145 call. ROKU was last seen down 1% at $142.17, pulling back from last session's four-year highs.
Western Digital Corp (NASDAQ:WDC) is riding the memory chip wave today, up 13.2% at $637.25 at last glance, earlier tapping an all-time high of $658.80. Continuing the wave of price-target hikes WDC has received of late, Morgan Stanley lifted its price objective to $650 from $488 today. Gapping above the $600 level, which kept a lid on gains earlier this month, the equity is up 274% year to date.
Fiserv Inc (NASDAQ:FISV), on the other hand, is trading at 10-year lows. The stock was last seen down 8.2% at $49.66, after news that CEO Mike Lyons is leaving the company to take up the role of CEO at Truist Financial Corporation (TFC). Since the start of the year, FISV is down roughly 26%.
Key Takeaways Chip, memory, and data storage stocks led markets higher Monday, as the AI trade recovers from a recent pullback.Western Digital, Seagate, Micron Technology, Advanced Micro Devices, and Intel were some of the biggest gainers in the S&P 500 and Nasdaq. Get personalized, AI-powered answers built on 27+ years of trusted expertise.
The AI trade is off to a strong start this week.
Chip, memory, and data storage stocks were leading markets higher Monday, amid a broad rally after the U.S. reached a peace deal with Iran, as the sector looks to bounce back from a sell-off that slowed the AI trade's momentum earlier this month.
Hard drive makers Western Digital (WDC) and Seagate (STX) were the biggest gainers in the S&P 500 and Nasdaq, with shares up 14% and 9% to new highs, respectively. Memory chipmaker Micron Technology (MU), with shares up around 9%, were less than 2% off their highs earlier this month.
Shares of AI chipmaker Advanced Micro Devices (AMD) surged 9% to a fresh record before paring back some of those gains, while Intel (INTC) climbed close to 4%, nearing last month's record. Nvidia (NVDA) and Broadcom (AVGO) were also higher, with shares up about 2%.
Why This Matters to Investors The AI trade's strong start Monday could be an encouraging sign for how markets will perform this week.
The moves across the chip sector helped send the Philadelphia Semiconductor Index (SOX) up over 4% to a fresh record high. The Roundhill Memory ETF (DRAM) was up 6% recently, just under highs set earlier this month.
Wedbush analysts said Monday that they also see the market's welcoming reception to SpaceX's (SPCX) market debut as a "Goldilocks outcome" that could be taken as an encouraging signal for the AI trade.1
Some concerns around whether many AI stocks have climbed too high, too quickly had given way to a pullback in recent weeks, interrupting a record runup after a flurry of strong earnings reports as big tech companies continue to spend heavily on AI hardware.
Western Digital (NASDAQ:WDC | WDC Price Prediction) has become the AI storage trade nobody saw coming a year ago. The pure-play HDD maker, post-Sandisk spinoff, just delivered a quarter where gross margin crossed 50% for the first time and revenue jumped 45.47% year over year.
CEO Irving Tan put it bluntly on the Q3 FY26 call: “Virtually every AI workload, from training, inference, agentic AI to physical AI, creates data that is stored persistently and cost-efficiently on HDDs.”
Shares are up 227.02% YTD. The question I want to answer: can WDC actually punch through $600?
What’s Holding Western Digital Back Right Now “Stuck” is generous. Shares ran 10.01% in the past week and 13.97% in the past month. The real friction is valuation gravity at these levels. After a 911.87% one-year move, every uptick invites profit-taking. With beta of 2.2, this name swings hard in both directions.
Morningstar has flagged that “most of these stocks are currently overvalued and lack durable competitive advantages,” and insider activity has skewed toward selling on 155 recent transactions. Shares also sit 9% below the 52-week high of $602.38, where shares ran into a wall the first time. Until WDC reprints that level and holds it, the stock is digesting, not breaking out.
Wall Street Sees Modest Upside. Our Model Sees Less Wall Street consensus is $547.09, which actually sits below today’s price. The rating split: 4 Strong Buy, 17 Buy, 3 Hold, 0 Sell, and 1 Strong Sell. That’s an 84% bullish consensus, but on price they’ve been chasing the chart.
Our base case lands at $544.99 with 90% confidence, a modest -3.2% from here, with an optimistic case of $643.80 and a bear case of $396.65. My honest read: analysts are anchored to stale targets and will be dragged higher only after the Q4 earnings report. The earnings power is moving faster than their models.
The Path to $600 Per Share Reaching $600 from today’s price of $562.92 would require a gain of 6.6%. That’s one good earnings reaction away.
With forward EPS of $12.43, a price of $600 implies a forward P/E of 48x. Our base case of $544.99 already implies 68x on a different EPS basis, so the multiple expansion math actually works in reverse here: $600 looks reasonable against forward earnings power if Q4 FY26 guidance of $3.25 EPS hits.
The catalysts are stacking. WDC has tripled in 2026 on the AI storage cycle, CFO Kris Sennesael cited the ability to meet exabyte demand through higher-capacity drives rather than new factories, and the 40-terabyte drive ramp is the next leg. Institutional ownership of 92.51% tells me the smart money is parked. The risk: any hyperscaler capex pause would slam this multiple fast.
Where Western Digital Trades Today vs Its Earnings Power At $562.92 against forward EPS of $12.43, WDC trades at a forward P/E of 45x. That looks rich until you remember Q3 FY26 net income grew 511.64% year over year and FCF rose 158.05%.
Shares sit between a 52-week low of $56.12 and a high of $602.38, and the 10-year return stands at 1,745.72%. Earnings power is finally catching up to the multiple, which is exactly what a $600 print needs.
Is $600 Realistic? Here’s My Take $600 from $562.92 requires 6.6%. With Q4 FY26 guiding revenue of $3.65 billion and EPS of $3.25, this is realistic and well within reach.
Three things need to go right: Q4 delivers another beat, the 40TB drive ramp lands on schedule, and hyperscaler capex commentary stays constructive into fall. What derails it? Any meaningful pricing reset in HDDs. Returns at this level shouldn’t be expected every year, but we’ve outlined the blueprint for how Western Digital could reach $600 in 2026.
Western Digital WDC shares surged on Monday after Morgan Stanley raised its price target on the data-storage company.
The firm also reiterated its bullish outlook on Seagate Technology, citing strengthening demand for artificial intelligence-driven hard disk drives.
Western Digital stock jumped about 17% to $658.80, making it the top performer in the S&P 500.
The shares have gained more than 1,000% over the past year.
Seagate Technology also advanced 7.6% to $1,002.44 and has climbed more than 660% during the same period.
Morgan Stanley analyst Erik Woodring reiterated Overweight ratings on both companies, describing them as his "most-favored Overweights."
The firm increased its price target on Western Digital to $650 from $488 and raised its target on Seagate to $1,035 from $767.
According to Morgan Stanley, growing demand for data storage driven by artificial intelligence is creating favorable industry conditions that appear more durable than previous hardware cycles.
"We continue to believe [hard disk drives] represent the cleanest estimate revision and re-rating story within our IT Hardware coverage," Woodring wrote.
The firm estimates that hard disk drive, or HDD, supply will fall short of demand by 10% to 15% in 2026.
Demand is currently growing at roughly 40% to 50% annually as AI models consume and generate increasing amounts of data, while HDD supply growth is estimated at 30% to 35%.
Morgan Stanley argued that this imbalance could support continued pricing gains and revenue growth across the sector.
Earlier this year, Western Digital Chief Financial Officer Kris Sennesael told Barron's that the industry has become less cyclical, noting that customers are increasingly seeking to secure supply several years in advance.
The brokerage also highlighted signs of tightening inventory levels.
Following meetings with Western Digital executives, analysts noted that original design manufacturers currently hold only one to two weeks of HDD inventory.
"Demand is strengthening with ODMs [Original Design Manufacturers] currently running with only 1-2 weeks of HDD inventory, implying limited 'inventory glut' risk," the analysts said.
Morgan Stanley expects stronger demand to continue supporting pricing improvements.
Western Digital and Seagate currently sell HDDs for approximately $14.30 to $14.90 per terabyte.
According to the firm, both companies are targeting pricing of $25 to $30 per terabyte in 2027 and 2028.
Separately, J.P. Morgan analyst Samik Chatterjee noted that Seagate has stopped offering discounts to encourage adoption of next-generation products, reflecting ongoing supply constraints.
Morgan Stanley also highlighted Western Digital's dual-track UltraSMR and HAMR technology roadmap as an underappreciated advantage.
"Our mgmt meetings reaffirm that: (1) HDD demand is strengthening with customers seeking visibility into 2032; (2) WDC price/TB is biased upwards; (3) WDC's UltraSMR/HAMR products are on-track for C2H26/C1H27 launch; and (4) capital returns are accelerating. PT to $650, Bull Case to $920," the analysts wrote.
The firm said HAMR qualifications with four hyperscale customers remain on track for a first-half 2027 launch.
Following meetings with Chief Executive Officer Irving Tan, Chief Financial Officer Kris Sennesael, and Vice President of Investor Relations Ambrish Srivastava, Morgan Stanley said it has increased confidence in Western Digital's outlook.
The analysts expect the company to benefit from more than 30% year-over-year growth in nearline exabytes, accelerating pricing gains, expanding gross margins, and stronger operating leverage.
Management also suggested that exabyte supply growth could compound at 30% to 35% annually over the next three to five years, with a 40% compound annual growth rate potentially achievable without adding manufacturing capacity.
Morgan Stanley believes investors continue to underestimate the potential upside from rising HDD demand, stronger pricing, and accelerating shareholder returns.
The firm's bull-case scenarios value Western Digital at $920 per share and Seagate at $1,446 per share.
"The drivers of HDD demand are broadening, visibility is elongating, pricing is strengthening, and our new bull cases are coming closer into play," Woodring wrote.
KFC is launching what it calls its "next chapter" globally, rolling out new menu items, redesigned restaurants and refreshed branding as the fast-food giant looks to strengthen its position in the increasingly competitive chicken market.
The Yum Brands-owned chain said Monday that the initiative will eventually touch its more than 34,000 restaurants across over 150 countries. KFC noted that a new restaurant opens somewhere in the world roughly every 3.5 hours.
"As the global appetite for chicken grows, KFC is answering the call," KFC Global CEO Scott Mezvinsky said in a statement. He added that the company sees an opportunity to "set the standard for modern chicken" in the quick-service restaurant industry.
MAJOR CARL'S JR OPERATOR REPORTEDLY SET TO SHUTTER, SELL DOZENS OF CALIFORNIA LOCATIONS
KFC updated its famous logo and added new items to its menu as part of a new brand strategy. (KFC)
A key component of the strategy centers on menu innovation. KFC plans to expand its lineup of boneless chicken offerings, including tenders designed for dipping and snacking, while introducing more than 20 new sauces tailored to local tastes. Examples include Chimichurri Ranch and Hot Honey Habanero.
The company is also betting on growing consumer demand for customizable, sauce-focused meals, with new menu items featuring chicken tenders, wings and sandwiches coated in bold flavors.
Ticker Security Last Change Change % YUM YUM! BRANDS INC. 154.31 +1.04 +0.68% Beyond food, KFC is expanding its beverage platform, known as "KWENCH by KFC," which includes boba refreshers, milkshakes, sparkling lemonades and iced coffees. The beverage lineup is moving from a pilot program to permanent menus in Australia and Canada this year.
Miami, Florida, Miami International Airport, airport terminal, KFC, Kentucky Fried Chicken fast food restaurant. (Jeffrey Greenberg/Universal Images Group via Getty Images)
KFC said the changes are intended to give customers more reasons to visit throughout the day, whether for snacks, drinks or full meals.
COSTCO FANS ERUPT AFTER BELOVED FOOD COURT ITEM REPLACED BY HIGH-CALORIE NEWCOMER
The company is also introducing a new generation of restaurant designs aimed at creating more modern dining experiences. The first U.S. example is expected to open in McKinney, Texas, later this summer and will feature an open-concept layout. A larger two-story flagship location is scheduled to debut in Dubai this fall.
KFC’s next-generation restaurant concepts are designed to create more modern, dynamic and hospitality-driven experiences for guests around the world. (KFC)
The brand refresh extends beyond menus and restaurants. KFC said it is updating its visual identity across packaging, advertising and digital platforms while retaining its signature bucket and Colonel Sanders branding.
CLICK HERE TO GET FOX BUSINESS ON THE GO
The rollout begins in the United Kingdom and Ireland, with expansion to the United States and Australia expected in the coming weeks. Additional markets will follow through 2026.
Yum Brands shares are fractionally higher in afternoon trading and are up more than 2.5% year to date.
More than 100 days since the start of the Iran war, investors are still struggling to predict when or how it might conclude. Between headlines about a ceasefire and renewed attacks, it's difficult to assess how the conflict may continue—and what the impacts may be on the market.
U.S. stock futures are sharply higher on Monday, looking to extend last week's gains after President Donald Trump announced an agreement had been reached to end the conflict between the United States and Iran. Oil prices are falling as well after Trump said he authorized the reopening of the Strait of Hormuz, helping lift sentiment heading into the holiday-shortened trading week. Meanwhile, SpaceX (SPCX) is up 5.6% before the bell after Friday's record-setting initial public offering (IPO).
Continue reading for more on today's market, including:
Unpacking the Nasdaq and S&P 500's worst days of the year. Put support emerged for Cboe Global Markets stock. Plus, more on SPCX, Paramount moves in on Warner Bros, and DAL eyes record highs.
5 Things You Need to Know Today The Cboe Options Exchange saw more than 8.9 million call contracts and 6.7 million put contracts traded on Friday. The single-session equity put/call ratio fell to 0.76, while the 21-day moving average stayed at 0.59. As mentioned above, SpaceX (NASDAQ:SPCX) shares are 5.6% higher before the bell, as traders share optimism on the stock's debut. The stock finished with 19% gain from its $135 IPO price on Friday. Streaming platform Paramount Skydance (NYSE:PSKY) is up 2.6% premarket after the U.S. Justice Department approved the company's long-fought acquisition for Warner Bros. Discovery. The company shed 40% over the last nine months. Travel stocks are continuing Friday's run, with Delta Air Lines (NYSE:DAL) adding 4.2% ahead of the open today as the broader sector reacts to lower fuel prices. The stock is poised to open at a record high, topping its May 29 record high of $83.90. Heading into today, the equity has added 69% year-over-year. Investors are tuning in for the latest Fed interest rate decision, later this week.
SoftBank Rally Boosts Nikkei Asian markets rallied on Monday, boosted by tech stocks. Japan’s Nikkei jumped 5%, with SoftBank adding 10.3% to become the country’s most valuable company. The South Korean Kospi tacked on 5.2% as memory chip stocks surged, while China’s Shanghai Composite and Hong Kong’s Hang Seng rose 1.6% and 0.5%, respectively.
European markets are higher as well, on hopes that the U.S. and Iran will reach a peace deal. The French CAC 40 and German DAX are both up 1.3% at last glance, while London’s FTSE 100 inches up 0.09%.
Rivian Automotive (RIVN 0.45%) hasn't been a good stock to own in recent years. Since it went public in late 2021, it has plummeted more than 80% in value, as investors haven't been convinced of its growth story. Its poor financials also haven't helped things, either.
Recently, however, the company began shipping its new R2 SUV to customers, and the new vehicle may open up more growth opportunities for the business. Could this be the game changer the electric vehicle stock needs to take off in value, and is now a good time to buy shares of Rivian?
Image source: Getty Images.
A lower-priced vehicle could be great for sales, but poor for margins Electric vehicles (EVs) aren't typically known for being particularly affordable, which can be an impediment to growing sales for companies in this space. That's why the launch of the R2 is so significant for Rivian, as it may open the door to reaching a wider range of customers. At around $46,000, the R2's starting price is more affordable than its R1S, which starts at around $77,000.
The downside, of course, is that at a lower price, margins may be squeezed, which isn't great news for a company such as Rivian that already has poor margins to begin with. Over the trailing 12 months, its gross profit was just $57 million on revenue of $5.5 billion. Competition in the EV market has been intensifying, as even Tesla, a leader in the space, has struggled with reduced profitability in recent years.
Today's Change
(
-0.45
%) $
-0.07
Current Price
$
16.68
The stock has been rising recently, but there's no rush to buy right now Over the past month, Rivian shares have risen about 20% as investors have become more bullish on the stock following the launch of the R2. If the SUV proves popular with consumers and significantly improves the company's financials, there could be considerable upside for the EV stock in both the short and long term.
However, that's also why I don't think there's a rush to buy right now. You might sacrifice some gains by holding off if the R2 proves to be the catalyst that growth investors hope it will be for Rivian, but it's a far safer move, as Rivian still has a lot to prove. And even if you wait to buy the stock after it's proven that the R2 is a big hit, it may still have plenty of room to rise higher.
For now, a wait-and-see approach with Rivian's stock may make the most sense.
Key Takeaways QRVO is benefiting from organic growth across defense, aerospace, infrastructure and connectivity.Defense demand is rising from radar, military communications, electronic warfare and satellites.Connectivity and power management traction is helping Qorvo diversify beyond smartphones. Qorvo Inc. (QRVO - Free Report) is benefiting from several organic growth drivers that are helping it diversify beyond its traditional smartphone business. The company is expanding its opportunities across markets, customers and product categories while maintaining its commitment to technology leadership and productivity gains. Qorvo continues to capitalize on robust demand trends across defense, aerospace, infrastructure and connectivity markets, which are emerging as important contributors to revenue growth.
The company offers a complete product portfolio targeting the highest-growth segments of its market, including filters, switches and tuners. A diversified product portfolio, systems-level expertise, R&D focus, manufacturing scale and internal assembly and test capabilities are key growth catalysts of Qorvo.
Defense and Aerospace Momentum Bodes WellQorvo's High Performance Analog segment has been witnessing strong traction from defense and aerospace customers. Growing investments in radar systems, military communications, electronic warfare and satellite applications are driving demand for the company's advanced RF solutions.
The defense market offers attractive growth characteristics, including long product cycles, high barriers to entry and resilient demand patterns. As global defense spending remains elevated, Qorvo is well-positioned to benefit from the increasing opportunities in next-generation defense platforms.
Network Infrastructure Upgrade Acts as a TailwindThe company is also benefiting from higher investments by carriers to upgrade network infrastructure. Continued investments in wireless networks and communication infrastructure are supporting sales of Qorvo's RF products used in base stations and related equipment. As data consumption continues to rise and network operators expand capacity, infrastructure-related demand is expected to remain a favorable growth driver for the company.
Qorvo has introduced highly integrated front-end solutions that simplify and accelerate the implementation of multimode, multi-band 5G smartphones and tablets. These new RF Fusion front-end solutions showcase the company's ability to help leading OEMs quickly launch their next-generation flagship devices. Qorvo's RF Flex solutions have been selected to support multiple upcoming leading 5G reference designs. RF Flex delivers best-in-class current consumption to enable superior device performance and leading-edge design flexibility to simplify regional customization.
Connectivity Portfolio Gaining TractionThe company is witnessing increased adoption of its connectivity solutions, particularly in Wi-Fi and ultra-wideband technologies. These solutions are being used across smartphones, smart home devices, automotive platforms and industrial markets. As connected devices become increasingly sophisticated, Qorvo stands to benefit from rising demand for high-performance connectivity solutions.
Qorvo has also taken giant strides in its power management business, which serves applications across storage, industrial and computing markets. Improving demand trends and healthier inventory levels are supporting growth in this business. The expanding adoption of power-efficient electronic systems across industries provides Qorvo with an opportunity to increase its market presence and diversify revenue streams.
Price PerformanceQorvo has surged 22.1% in the past year against the industry’s decline of 0.5%. It has outperformed peers like Skyworks Solutions, Inc. (SWKS - Free Report) but lagged RF Industries, Ltd. (RFIL - Free Report) . While Skyworks has gained 2.7%, RFIL soared 319.4% over this period.
One-Year Price Performance of QRVO
Image Source: Zacks Investment Research
Moving ForwardQorvo's expanding presence across defense and aerospace, infrastructure, power management and connectivity markets highlights the strength of its organic growth strategy. With multiple secular growth drivers supporting demand, the company appears well-positioned to deliver sustainable long-term growth while reducing its reliance on smartphone-related revenue streams.
Qorvo currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
With a favorable Zacks Rank and healthy growth dynamics, Qorvo appears primed for further stock price appreciation. Consequently, investors are likely to profit if they bet on this stock now.
RKLB stock is moving. See the chart and price action here. Analyst Michael Leshock established a $135 price target on RKLB, implying 26% upside from current levels, while FLY’s $50 target carries 48.5% upside.
KeyBanc sees the same structural tailwinds intact: exponential satellite constellation growth, a chronically undersupplied launch market and a proposed U.S. defense budget of $1.07 trillion that earmarks $56 billion for space-based systems, nearly double this year's levels.
Rocket Lab Bull Case For Rocket Lab, KeyBanc’s bull case centers on Neutron, the company’s forthcoming medium-lift rocket, set for its debut launch later this year.
With Falcon 9 slated to sunset as Starship scales and much of SpaceX’s own capacity consumed internally, Leshock sees a wide-open medium-lift market where Neutron could capture tens of billions in annual revenue.
Rocket Lab's backlog of more than $2.2 billion as of Q1, along with a pending Mars Telecommunications Orbiter contract estimated at $700 million, adds near-term catalysts. The stock will also join the Nasdaq-100 on June 22.
At roughly 50 times forward price/sales on FY27 estimates, shares trade above their historical ~40 times average, but KeyBanc’s $135 target implies ~67 times — a premium it says is warranted given RKLB’s vertical integration and positioning as the clear No. 2 commercial launch provider.
Firefly Bull Case KeyBanc pegs Firefly’s upgrade to its unique NASA leverage.
The company’s Blue Ghost lunar lander stands as the only commercial vehicle to achieve a fully successful Moon landing, putting Firefly in position for future Commercial Lunar Payload Services awards as NASA aims for a monthly lander cadence starting in 2027.
A freshly awarded $75 million MoonFall contract for its Elytra spacecraft prompted modest FY26/FY27 estimate bumps from the firm.
Firefly's SciTec missile tracking software adds a defense angle — SciTec tracked roughly 1,000 missiles in the first 30 days of the Iran conflict — and the stock’s ~6.5 times FY27 price/sales sits at the low end of a 5-15 times peer range that KeyBanc views as unwarranted.
Photo by Andrei Armiagov via Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
Rocket Lab RKLB shares climbed more than 6% on Monday after KeyBanc Capital Markets upgraded the stock, arguing that the recent selloff across space-related equities following SpaceX's blockbuster public debut was overdone.
The rally came as investors returned to space stocks after a sharp decline on Friday, when Elon Musk-led SpaceX began trading on the Nasdaq and quickly became one of the most valuable publicly listed companies in the market.
Rocket Lab shares rose to around $110.60, recovering part of the 11% decline recorded on Friday.
Firefly Aerospace also gained more than 6%, rebounding from a 19% drop in the previous session.
Meanwhile, SpaceX extended its gains, rising another 8% after surging 19% during its debut.
KeyBanc analyst Michael Leshok upgraded both Rocket Lab and Firefly Aerospace to Overweight from Sector Weight.
The firm assigned a $135 price target to Rocket Lab and a $50 target to Firefly, implying meaningful upside from current trading levels.
“Last Friday’s record-setting SpaceX IPO sent ripple effects across our coverage of space-centric equities, with the sector selling off sharply on IPO day and over the weeks leading up to it,” Leshok wrote. “We think this is unwarranted and largely systematic in nature, as funds make room for the space behemoth.”
The analyst argued that the sector-wide weakness was not driven by deteriorating fundamentals but rather by portfolio repositioning as investors allocated capital toward SpaceX following its public listing.
The selloff affected several space companies.
Alongside Rocket Lab and Firefly, shares of AST SpaceMobile, Intuitive Machines, Voyager Technologies and Redwire all posted double-digit declines on Friday. Most of those stocks recovered some ground on Monday.
Fundstrat economic strategist Hardika Singh also highlighted the disconnect between SpaceX's success and the performance of other space stocks.
“It’s been a great June for space investors, but that was felt only if you held shares of SpaceX and SpaceX only,” Singh said in a Barron's report.
“Over the past year, investors had heavily bought into space…. But over the past month, they’ve been obliterated by investors selling their winners to raise cash in favor of the real deal,” she added.
Neutron rocket remains a key growth catalystA major part of KeyBanc's bullish thesis centers on Rocket Lab's expanding position in the commercial launch market.
The firm described Rocket Lab as the second-largest player in the commercial space launch industry behind SpaceX.
Its Electron launch vehicle has completed approximately 90 successful missions.
KeyBanc also expressed confidence in Rocket Lab's Neutron rocket program, which remains on track for its inaugural launch later this year.
According to the firm, additional visibility into the project over the past six months has increased confidence in the program, while a testing anomaly encountered in January has been fully resolved.
Leshok noted that Rocket Lab's combination of launch services, satellite design, and manufacturing capabilities provides strategic flexibility as the commercial space market continues to evolve.
“SpaceX’s premium valuation shows the value of having in-house access to space and the myriad of potential end-use applications that come with that capability. We continue to expect these applications to evolve over time and believe Rocket Lab is among the best positioned to adapt to the dynamic market given its satellite design/manufacturing and launch heritage,” Leshok added.
Investor optimism has also been supported by Rocket Lab's recent financial performance and upcoming inclusion in the Nasdaq-100 index.
The company reported first-quarter revenue of $200.35 million, exceeding analyst expectations of $189.65 million and representing year-over-year growth of 63.4%.
Earnings per share came in at negative $0.07, matching Wall Street forecasts.
Rocket Lab is scheduled to join the Nasdaq-100 on June 22, a move that could generate additional demand from index-tracking funds and exchange-traded products managing hundreds of billions of dollars in assets.
Stifel recently raised its price target on Rocket Lab to $132 from $110 while maintaining a Buy rating, citing strong revenue growth and an expanding contract backlog.
Investors in Array Technologies, Inc. (ARRY - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $2.00 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?Clearly, options traders are pricing in a big move for Array Technologies shares, but what is the fundamental picture for the company? Currently, Array Technologies is a Zacks Rank #3 (Hold) in the Solar industry that ranks in the Bottom 32% of our Zacks Industry Rank. Over the last 60 days, no analysts have increased their earnings estimates for the current quarter, while five analysts have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from 23 cents per share to 12 cents in that period.
Given the way analysts feel about Array Technologies right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
Key Takeaways MIRM/INCY reported positive phase II data showing zilurgisertib met the primary endpoint in FOP patients.The investigational therapy reduced new HO lesion formation by 81% versus placebo and met key secondary goals.MIRM and INCY's zilurgisertib NDA received FDA Priority Review, with a decision due by Sept. 26, 2026. Mirum Pharmaceuticals (MIRM - Free Report) and Incyte Corporation (INCY - Free Report) have reported positive pivotal phase II results from Cohort 1 of the PROGRESS study evaluating zilurgisertib, an investigational oral ALK2 inhibitor, in adolescent and adult patients with fibrodysplasia ossificans progressiva (FOP). The data showed that the investigational oral therapy significantly reduced new heterotopic ossification (HO) lesion formation, meeting the study’s primary endpoint. Key secondary endpoints, including lesion volume measures and disease flare activity, were also met, supporting zilurgisertib’s potential as a new treatment option for the ultra-rare disease.
FOP is a rare genetic disorder in which muscle, tendons and other soft tissues progressively transform into bone, causing irreversible loss of mobility and severe disability over time. Based on the positive pivotal study findings, the FDA has accepted the new drug application (NDA) for zilurgisertib for FOP and granted Priority Review status. The agency is expected to deliver its decision regarding the NDA by Sept. 26, 2026.
A filing accepted under the FDA’s Priority Review pathway reduces the review period to six months from the standard 10 months. This status is awarded to marketing applications for medicines intended to treat serious conditions and that, if approved, would offer a substantial improvement in safety, effectiveness, prevention, or diagnosis of such conditions. Mirum licensed worldwide development and commercialization rights to the candidate from Incyte.
Year to date, MIRM and INCY’s shares have risen 25.7% and 9.9%, respectively, against the industry’s 1.4% decline.
Image Source: Zacks Investment Research
MIRM/INCY's Pivotal Phase II FOP Study Data in DetailsThe pivotal phase II PROGRESS study is evaluating the safety and efficacy of zilurgisertib in FOP patients. Cohort 1 enrolled 63 patients aged 12 years and older, who were randomized equally to receive either zilurgisertib 100 mg once daily or placebo for 24 weeks, followed by an open-label extension period. At the time of analysis, 61 patients had available 48-week whole-body CT scan data.
The primary endpoint assessed the proportion of patients developing new HO lesions at Week 24. Results showed that only one patient (3.1%) in the zilurgisertib arm developed a new lesion compared with five patients (16.7%) in the placebo group, representing an 81% reduction. The treatment demonstrated consistent benefits across several secondary efficacy measures.
Mirum and Incyte reported particularly strong effects on new lesion burden. Patients receiving zilurgisertib experienced a 99.9% reduction in the total volume of newly formed HO lesions compared with placebo at Week 24. The mean volume of new lesions was nearly eliminated in the treatment arm, highlighting the drug's ability to suppress abnormal bone formation. Treated patients also developed fewer new lesions overall compared with placebo recipients.
The study also showed favorable effects on overall disease burden. Patients receiving zilurgisertib experienced a reduction in total HO lesion volume by Week 24, whereas total lesion volume increased among placebo-treated patients. Annualized flare activity was likewise lower in the treatment arm, with patients receiving zilurgisertib reporting fewer new disease flares than those receiving placebo.
Results from the open-label extension demonstrated sustained benefit through Week 48. No new HO lesions were observed among patients who continued receiving zilurgisertib, and no new lesions were reported in patients who crossed over from placebo to active treatment after Week 24. Total HO lesion volume continued to decline in both groups through Week 48, while flare activity remained low over the extended treatment period.
The safety profile remained favorable throughout the placebo-controlled portion of the study. Most adverse events were mild to moderate in severity, and no patients discontinued treatment or required dose reductions because of adverse events.
With positive pivotal data now in hand and Priority Review underway, Mirum and Incyte are moving closer to potentially bringing zilurgisertib to patients with FOP, a population with limited treatment options and significant unmet medical need.
MIRM/INCY’s Zacks Rank and Stocks to ConsiderMirum and Incyte currently carry a Zacks Rank #3 (Hold) each.
Some better-ranked stocks in the biotech sector are Liquidia Corporation (LQDA - Free Report) and Immunocore (IMCR - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Over the past 60 days, estimates for Liquidia Corporation’s 2026 EPS have increased from $1.50 to $2.97. Over the same period, EPS estimates for 2027 have also increased from $2.91 to $4.81. LQDA shares have rallied 106.7% year to date.
Liquidia Corporation’searnings beat estimates in three of the trailing four quarters and missed in the remaining one, with the average surprise being 54.40%.
The estimate for Immunocore’s 2026 EPS is currently pegged at 6 cents. In the past 60 days, the estimates for its 2027 EPS have increased from 24 cents to 87 cents. IMCR shares have lost 16.5% year to date.
Immunocore’s earnings beat estimates in three of the trailing four quarters, while missing the same on the remaining occasion, with the average surprise being 46.66%.
Dick's Sporting Goods, the sporting goods retailer, announced a partnership to expand Lids shops to 100 Dick's stores nationwide, the company said in a press release on Monday.
"Our athletes are increasingly looking for new ways to rep their favorite teams, their style and the latest trends," said David Progar, SVP, Licensed at Dick's. "By partnering with Lids, a leader in licensed headwear, we'll be able to offer them more choices to meet their needs for sport, lifestyle and fandom."
The collaboration is currently available in 46 stores across states such as California, Colorado, New York, and Texas. It's expected to reach 100 stores by late summer 2026.
Dick's first-quarter earnings missed Wall Street expectations, as the costly turnaround of its legacy sneaker store Foot Locker weighed on the bottom line.
During the quarter, Dick's saw net income of $319.82 million, or $3.54 per share, compared with $264.29 million, or $3.24 per share, a year earlier.
— CNBC's Gabrielle Fonrouge contributed to this report.
The artificial intelligence (AI) trade has thus far been largely restricted to data center infrastructure. Companies selling AI hardware, such as chips, servers, and networking components, have witnessed a remarkable increase in revenue and earnings in recent years.
Nvidia (NVDA +3.19%) is one of the biggest examples of how the booming demand for AI data center components has transformed a company's fortunes. Its revenue in fiscal 2023 (which ended in January 2023) was $27 billion. That was just before Nvidia started benefiting from the AI-fueled demand for its graphics processing units (GPUs).
The introduction of ChatGPT in November 2022 gave Nvidia a massive boost, as customers made a beeline for its GPUs to train and deploy AI models. It is now the largest company in the world and is expected to clock a whopping $392 billion revenue in fiscal 2027. That points toward a jump of over 14x in just four years.
AI, however, is now moving from data centers into real-world applications that are closer to users, which require processing at the edge. This explains why Nvidia is looking to capitalize on the growing demand for AI-powered robots, cars, drones, and robotic arms. These physical devices need to run AI workloads locally to make real-time decisions.
Investing in Nvidia stock could help you make the most of this fast-growing niche, especially considering that the company is a pioneer in AI. However, there's a relatively little-known semiconductor company -- Ambarella (AMBA +3.58%) -- that's making steady progress in this space.
Let's look at the reasons why the adoption of AI in edge computing devices could be a massive tailwind for this semiconductor stock in the long run.
Image source: Getty Images.
Ambarella has the potential to win big from the growing adoption of AI at the edge Edge AI applications will expand the productivity gains of this technology. For instance, an AI-capable drone can chart its path and deliver to customers, or a humanoid robot can solve complex tasks and assist humans. Not surprisingly, the size of the edge AI market is anticipated to jump from $25 billion in 2025 to almost $119 billion in 2033, clocking a compound annual growth rate of nearly 22%, according to Grand View Research.
Today's Change
(
3.58
%) $
2.43
Current Price
$
70.21
Ambarella is a pure-play edge AI semiconductor company. It primarily designs chips for the automotive and the Internet of Things (IoT) markets. The company noted in its May earnings call that it has shipped more than 46 million edge AI chips so far, and the growing demand for inference and physical AI applications is likely to expand its addressable market at a nice pace in the future.
Importantly, Ambarella now sees customers entering into long-term agreements (LTAs) for multiple generations of its chips. The good part is that Ambarella struck its first LTA last quarter "to develop a semi-custom ASIC for a customer who wants to support a certain complex AI workload." And now, the company has entered into another LTA with South Korean company Hanwha "for the sourcing and co-development of Ambarella's edge AI technology across Hanwha's product lines and industries, including physical security, operational automation, life sciences, robotics and other industry markets."
Ambarella estimates that this new agreement could help it generate more than $800 million in revenue over a decade, adding that it is one of the largest agreements that it has signed in its history. The company is in discussions with additional companies to sign LTAs, suggesting its revenue pipeline is likely to improve further.
Meanwhile, Ambarella is gaining traction in the robotics space, claiming it has more than 15 design wins across 30 customers. In all, Ambarella is well-placed to grow its business at a brisk pace in the long run. The company estimates that its serviceable addressable market (SAM) in edge AI will grow at an annual rate of 18% through fiscal 2031. More importantly, Ambarella believes its revenue during this period will grow faster than the end market.
That's the reason why Ambarella could turn out to be a top AI stock over the long run. In fact, there are already signs that Ambarella is well on its way to making the most of the secular growth of the edge AI market.
The company's healthy growth should translate into solid gains on the stock market Ambarella released its fiscal 2027 first-quarter results (for the quarter ended April 30) on May 28. Its revenue increased by 17% year over year to $100.4 million. Earnings per share grew at a much stronger pace of 57% to $0.11 per share. The company expects its revenue to increase by 13% year over year in the current quarter to $108 million, based on the midpoint of its guidance range.
However, the design wins and the new agreements Ambarella has been signing indicate it could deliver stronger-than-expected growth. Analysts expect its revenue to grow by 13% in the current fiscal year to $441 million, followed by a gradual pickup going forward.
Data by YCharts
However, if Ambarella lives up to its claim of exceeding the 18% annual growth it expects for its edge AI SAM through fiscal 2031, it could easily beat market expectations. Also, the company has been delivering impressive earnings growth, and the gradual top-line uptick should allow it to sustain that momentum going forward.
Ambarella is trading at 7.2 times sales right now. That's lower than the U.S. technology sector's average price-to-sales ratio of 9.5. Assuming it grows in line with consensus expectations and clocks $579 million in sales in fiscal 2029, its market cap could jump to $5.5 billion (if it trades at the U.S. tech sector's average sales multiple at that time).
That's a potential gain of 85% from current levels, which is why investors looking for the next AI chip winner would do well to take a closer look at Ambarella before it starts soaring.
Key Takeaways Targa Resources gained 58.9% in a year, outperforming peers, its sub-industry and the broader energy sector.TRGP is advancing major projects and expanding LPG exports with rising demand and new long-term contracts.Targa Resources faces Permian concentration risk, weak Waha gas prices, high capex and a premium valuation. Targa Resources Corp. (TRGP - Free Report) has posted an impressive performance over the past year, with its shares rising 58.9%. This gain outperformed the sub-industry and the broader energy sector’s growth of 39% and 28.9%, respectively. Peer comparison further highlights its strength, as Targa Resources significantly outpaced rivals Sunoco LP (SUN - Free Report) , Western Midstream Partners, LP (WES - Free Report) and CrossAmerica Partners LP (CAPL - Free Report) , which lagged behind with just 23.4%, 15.9% and 4% growth, respectively, during the same period. Targa Resources’ stronger upward momentum reflects greater investor confidence and more consistent resilience.
Targa Resources is a leading North American midstream energy company headquartered in Houston, specializing in natural gas and NGL services. Its core operations include gathering, compressing, processing and marketing natural gas, along with handling crude oil and LPG-related services. A key strength is its integrated NGL pipeline and fractionation network, which connects major inland basins to Mont Belvieu, enabling efficient transport of over one million barrels per day and supporting global demand through fee-based revenues.
The company has a strong footprint in the Permian Basin and operates across other regions like Eagle Ford, Barnett, Anadarko, Williston and the Gulf Coast, ensuring diversification. Its business is divided into Gathering & Processing and Logistics & Transportation segments, covering upstream processing and downstream NGL transportation, storage and marketing. With rising performance indicators, it’s worth exploring the factors behind Targa Resources’ recent strength and what they mean for its near-term outlook.
Factors Favoring TRGP Stock’s GrowthMassive Multi-Year Growth Pipeline Already Under Construction: One of Targa Resources’ strongest investment attributes is its extensive backlog of growth projects. The company currently has multiple processing plants, fractionators, pipeline projects and export expansions under construction. Management announced two additional Delaware Basin gas processing plants that are expected to begin service in 2028. These projects are not speculative but are largely backed by customer demand and existing contracts. Historically, Targa Resources has brought 27 major projects online over six years, including 16 processing plants and five fractionators — all on time or ahead of schedule. This proven execution record significantly reduces project risk while creating visible EBITDA growth opportunities through 2027 and 2028, boosting investors’ confidence that future earnings expansion is already largely embedded in the capital program.
Growing Exposure to Global LPG Export Demand: Targa Resources' LPG export business has become an increasingly valuable earnings driver. The company reported strong demand for U.S. Gulf Coast LPG exports and expects record loading volumes in the second quarter. Management noted rising interest in long-term export contracts from customers around the world and indicated that the company is securing additional multi-year agreements. The ongoing expansion of the Galena Park export facility, which will increase capacity to over 19 million barrels per month, positions Targa Resources to benefit from growing global demand for propane and butane. Since export economies are often less dependent on domestic energy prices and more tied to global supply-demand dynamics, this business provides an attractive source of diversification and long-term growth.
Strong Balance Sheet and Financial Flexibility: Targa Resources enters this major growth phase from a position of financial strength. The company completed a $1.5 billion debt issuance during the quarter, ending with approximately $3.1 billion of available liquidity. Its leverage ratio remains around 3.6x, comfortably within management's target range of 3.0x to 4.0x. This financial flexibility allows Targa Resources to fund its significant capital spending program while continuing to return cash to shareholders. Importantly, the company does not appear financially stretched despite its aggressive expansion plans. A healthy balance sheet reduces refinancing risk, provides flexibility during commodity market downturns and positions Targa Resources to pursue attractive acquisitions should opportunities arise in the future.
A Positive 2026 Earnings Estimate: The Zacks Consensus Estimate for TRGP’s 2026 earnings is pegged at $10.75 per share, indicating 26.6% year-over-year growth. Additionally, the consensus mark for 2026 revenues is pegged at $19.3 billion, also implying a 13.1% year-over-year rise. The positive earnings estimate outlook makes the stock attractive for investors. In comparison to Targa Resources, the Zacks Consensus Estimate of the above-mentioned peer companies, namely Sunoco, Western Midstream and CrossAmerica Partners, also indicates positive year-over-year growth for 2026.
TRGP’s Earnings Estimate Overview
Image Source: Zacks Investment Research
Challenges for TRGP StockHeavy Dependence on the Permian Basin: While the Permian Basin is a major growth driver, it also creates concentration risk. A significant portion of Targa Resources’ gathering, processing, transportation and fractionation business depends on activity in a single region. If drilling activity slows due to lower oil prices, regulatory challenges, infrastructure bottlenecks or producer capital discipline, Targa Resources’ growth trajectory could weaken considerably. Although management remains bullish on long-term Permian activity, the company's future project economics and volume forecasts are closely tied to continued basin growth. Investors should recognize that any meaningful slowdown in the Permian could disproportionately affect Targa Resources compared with more geographically diversified midstream operators.
Persistent Waha Gas Price Weakness and Producer Shut-Ins: Management acknowledged that between 200 MMcf/d and 400 MMcf/d of production is currently being shut in by producers due to weak Waha natural gas prices and insufficient takeaway capacity. While Targa Resources has maintained its volume forecasts despite these curtailments, prolonged weakness could eventually impact throughput growth and earnings. The company is effectively relying on future pipeline expansions to relieve basin congestion. If those projects are delayed or if production growth continues to outpace takeaway additions, the Permian could remain oversupplied for longer than expected, reducing the expected volume uplift that investors are currently anticipating.
Elevated Capital Spending Requirements: Targa Resources expects approximately $4.5 billion of growth capital expenditures in 2026 alone. While these investments are intended to generate attractive returns, they represent a substantial financial commitment. Large capital programs expose investors to risks including construction delays, cost inflation, labor shortages, supply chain disruptions and lower-than-expected project utilization. Even though Targa Resources has an impressive execution record, the sheer scale of its current expansion program increases operational and financial complexity. If project economics deteriorate or producer growth slows, returns on these investments may not meet expectations, potentially reducing future shareholder value creation.
TRGP’s Premium Valuation: From a valuation perspective — in terms of Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization (EV/EBITDA) ratio — Targa Resources is trading at a premium of 14.94 compared with the industry average of 12.45. The stock is also trading above its five-year mean of 11.79.
TRGP’s Valuation
Image Source: Zacks Investment Research
Final Thoughts on TRGP StockTarga Resources remains a compelling midstream growth story, supported by a large backlog of contracted projects, expanding LPG export capacity, strong Permian Basin exposure, solid financial flexibility, expectations for double-digit earnings growth over the next two years and strong stock performance as compared to peers like SUN, WES and CAPL.
However, investors should balance these positives against meaningful risks, including heavy reliance on the Permian Basin, weak Waha gas pricing and producer shut-ins, elevated capital spending requirements and a premium valuation relative to both the industry and its historical average.
Given the company's attractive long-term growth prospects but limited margin for error at current valuation levels, retaining this Zacks Rank #3 (Hold) company appears prudent. Existing investors can benefit from future growth execution, while new investors may prefer to wait for a more attractive entry point or greater visibility on project returns and volume growth.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways XEL offers a higher 2.99% dividend yield, while ETR's yield is 2.30%; both top the S&P 500's 1.41%. ETR plans $57B in 2026-2029 investments; XEL targets $60B during 2026-2030 for grid upgrades. Rising power demand, data centers and grid upgrades are shaping growth prospects for both utilities. The companies belonging to the Zacks Utility- Electric Power industry, supported by its regulated structure, are engaged in producing and delivering electricity to a vast customer base throughout the United States. The regulated structure enables these utilities to recover investments while earning predictable returns. They enhance shareholder value through consistent dividend payments and planned share buybacks, making them a reliable choice for investors. Utilities are actively advancing the energy transition by rapidly increasing their reliance on cleaner energy sources to lower emissions.
Electricity demand in the United States is rising, fueled by data center growth, AI workloads, transportation electrification, higher residential usage and industrial reshoring. Companies operating in this industry are making strategic investments in renewable energy, grid modernization and distribution network upgrades to meet rising electricity demand.
Amid the rising importance of transmission and distribution companies, let us discuss Entergy Corporation (ETR - Free Report) and Xcel Energy Inc. (XEL - Free Report) . These two electric utilities have major investments in infrastructure development and grid modernization, making them comparable in the utility space.
Entergy, with its regulated structure, is engaged in electric power production and retail distribution of power. The company operates 25,000 MW of generating capacity, of which more than 5,000 MW is nuclear, supporting millions of customers throughout the United States. It is aided by contracted industrial growth and long-term service agreements supporting revenues and future growth. The company’s strategic investments in infrastructure development and renewable energy expansion enhance service reliability and support long-term growth.
Xcel Energy stands out with its regulated structure that operates through four regulated utility subsidiaries and serves millions of electricity and natural gas customers across the United States. XEL benefits from expanding customer base and a rise in data center demand, supporting revenues and earnings growth. The company invests systematically to expand renewable assets and infrastructure development, which enhances operational efficiency and strengthens long term financial performance.
Entergy and Xcel Energy are among the leading utilities. Comparing their fundamentals side by side can reveal which stock presents the most attractive investment opportunity.
ETR & XEL’s Earnings Growth ProjectionsThe Zacks Consensus Estimate for ETR’s earnings per share is pegged at $4.40 in 2026 and $5.03 in 2027, suggesting year-over-year growth of 12.53% and 14.39%, respectively. ETR’s long-term (three to five years) earnings growth is currently pinned at 13.32%.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for XEL’s earnings per share is pegged at $4.11 in 2026 and $4.49 in 2027, suggesting year-over-year growth of 8.16% and 9.17%, respectively. XEL’s long-term earnings growth is currently pinned at 9.36%.
Image Source: Zacks Investment Research
ETR & XEL’s Return on EquityReturn on Equity (ROE) plays a significant role in measuring a company’s management efficiency in utilizing shareholders’ funds to generate profit. A higher ROE generally signifies that a company is using its shareholder funds efficiently to create value and drive earnings growth.
Entergy’s current ROE is 10.75%, outperforming Xcel Energy, which reports a lower ROE of 10.37%. ETR utilizes shareholder capital more efficiently than XEL.
ETR & XEL’s Dividend YieldDividends are regular payments distributed by a utility company to reward its shareholders, reflecting a commitment to delivering consistent returns on invested capital. It reflects the company’s earnings stability and strong cash flow.
Currently, the dividend yield for Xcel Energy is 2.99%, while that for Entergy is 2.30%. The dividend yields of both companies are higher than the S&P 500’s yield of 1.41%.
Image Source: Zacks Investment Research
Capital Investment PlansThe Utilities sector requires continuous investments in infrastructure upgrades and maintenance to ensure operational efficiency and support growing demand. These investments ensure service reliability and help avoid outages even during extreme weather conditions.
Xcel Energy aims to invest $60 billion during 2026-2030 for grid modernization, expand renewable generation and deploy advanced technologies. Entergy plans to invest $57 billion during 2026-2029 to serve rising customer needs and expand the generation, transmission and distribution network.
Price PerformanceEntergy shares have gained 19.4% in the past six months compared with Xcel Energy’s rally of 6.7%.
Image Source: Zacks Investment Research
Overall AssessmentEntergy and Xcel Energy both gain from a rise in demand for service, expanding customer base and robust capital spending to reliably serve millions across the United States.
ETR, supported by stable earnings per share growth, stronger ROE and better price performance, appears to be a more attractive choice in the utility sector.
Based on the above discussion, Entergy currently has an edge over Xcel Energy, though both presently carry a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways Lumentum and Broadcom are gaining from AI infrastructure, cloud demand and data center connectivity.LITE posted record Q3 FY26 revenues of $808.4M, with AI demand boosting margins and sales.AVGO's AI chip revenues jumped 143%, but LITE's momentum makes it the stronger pick now. Lumentum Holdings (LITE - Free Report) and Broadcom (AVGO - Free Report) are two technology companies playing important roles in enterprise networking, cloud infrastructure and data center connectivity. Lumentum specializes in optical and photonic products used in high-speed communications, while Broadcom provides semiconductor and infrastructure software solutions powering enterprise and AI-driven networks worldwide.
Both companies are benefiting from rising demand for AI infrastructure, cloud computing and secure high-speed data transmission. Their technologies support the backbone of enterprise and hyperscale data centers, making them closely tied to the expanding digital economy.
Lumentum and Broadcom remain in focus as investors seek companies positioned to benefit from AI-led networking upgrades and rising enterprise spending on connectivity and security infrastructure. Let's dig in and find which stock offers the stronger investment case now.
The Case for LITE StockLumentum is strengthening its position as a leading AI networking and infrastructure enabler, benefiting from soaring demand for optical connectivity in hyperscale AI data centers. The company’s optical and photonic portfolio supports AI/ML workloads, cloud networking and data center interconnect applications through transceivers, laser chips, optical circuit switches (OCS), pump lasers and co-packaged optics (CPO).
Lumentum delivered a standout third-quarter fiscal 2026 performance, with revenues surging 90.1% year over year to a record $808.4 million. Non-GAAP operating margin expanded sharply to 32.2% from 10.8% a year ago, reflecting strong AI-driven demand and a favorable product mix. Components revenues surged 77.3%, while systems revenues jumped 121.1%, driven by cloud transceivers and AI networking products.
Management highlighted exceptionally strong demand for narrow-linewidth laser assemblies, pump lasers, 200G EMLs and optical interconnect technologies supporting 1.6T architectures. The company stated several AI-focused products remain effectively sold out for the foreseeable future. Lumentum is also ramping ultra-high-power laser chips for CPO applications and expects meaningful revenue contribution by late 2026.
A major growth catalyst is the acquisition of a fifth indium phosphide fabrication facility in Greensboro, NC, which expands long-term manufacturing capacity for AI optics and advanced laser technologies. The company’s OCS platforms are increasingly critical for scalable and energy-efficient AI clusters.
Lumentum is also benefiting from Nvidia’s multibillion-dollar optical networking agreements and strategic investments tied to next-generation AI switches and CPO deployments. The company expects fourth-quarter fiscal 2026 revenues of $960 million-$1.01 billion with non-GAAP EPS of $2.85-$3.05, underscoring strong AI infrastructure momentum.
The Case for AVGO StockBroadcom is gaining momentum as a leading AI infrastructure and AI networking provider, supported by accelerating hyperscale demand, expanding customer commitments and strong financial execution. The company’s semiconductor portfolio spans AI accelerators (XPUs), Ethernet switches, optical interconnects, SerDes, PCIe and networking fabrics that power AI data centers and large-scale AI clusters.
Broadcom’s AI momentum is translating into exceptional growth. In second-quarter fiscal 2026, total revenues surged 48% year over year to a record $22.2 billion, while AI semiconductor revenues jumped 143% to $10.8 billion. Networking contributed nearly 40% of AI revenues, highlighting Broadcom’s growing importance in AI connectivity infrastructure. Management expects AI semiconductor revenues to rise to $56 billion in fiscal 2026 and exceed $100 billion in fiscal 2027.
The company is benefiting from strategic AI partnerships with Google, Meta, OpenAI and Anthropic, supported by long-term agreements for custom AI accelerators and networking solutions.
Broadcom’s technology leadership in AI networking remains a major strength. The company is shipping the industry’s only 100-terabit Ethernet switch, Tomahawk 6, and is advancing next-generation 200-terabit switching technology. Its Jericho fabric solutions and co-packaged optics leadership further strengthen its competitive moat in AI infrastructure.
However, risks remain. Broadcom faces customer concentration risks, supply-chain dependencies, cyclical semiconductor demand fluctuations and rising competition in AI networking and accelerators. The company also carries substantial debt following major acquisitions, with long-term debt totaling $62.7 billion as of May 2026. Despite these risks, Broadcom’s scale, AI backlog, robust free cash flow generation and strong execution position AVGO favorably within the rapidly expanding AI infrastructure market.
LITE & AVGO: Price Performance and ValuationIn the year-to-date (YTD) period, Lumentum shares have skyrocketed 150%, immensely outperforming Broadcom’s 10.4% gain and the broader sector’s 15.7% growth, reflecting investors’ strong optimism around Lumentum’s accelerating AI-driven optical networking and margin expansion opportunities.
AVGO shares have underperformed as the company remains exposed to integration risks and execution challenges tied to large acquisitions, particularly VMware, while its sizable debt load continues to drive significant interest expenses. In addition, weakness in certain non-AI semiconductor markets and slowing enterprise spending on some infrastructure software products have acted as near-term headwinds despite strong AI networking demand.
LITE and AVGO YTD Stock Performance
Image Source: Zacks Investment Research
LITE shares are currently trading at a premium, as suggested by a Value Score of F. AVGO shares are relatively cheap compared to LITE, as suggested by a Value Score of D.
LITE’s forward 12-month P/S ratio of 13.23X is higher than AVGO’s 12.72X. Lumentum’s valuation premium is supported by its AI-driven optical networking growth, expanding margins and rapidly scaling cloud transceiver and laser chip businesses.
Price-to-Sales F12M
Image Source: Zacks Investment Research
How Do Earnings Estimates Compare for LITE & AVGO?The Zacks Consensus Estimate for LITE’s fiscal 2026 and 2027 earnings indicates increases of 298.54% and 115.37%, respectively. Over the past month, earnings estimates for both years have been unchanged.
LITE Estimate Trend
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for AVGO’s fiscal 2026 and 2027 earnings indicates 71.99% and 63.27% growth, respectively. Over the past month, earnings estimates for both years have been revised upward.
AVGO Estimate Trend
Image Source: Zacks Investment Research
LITE or AVGO: Which Stock to Invest in Now?While Broadcom remains a dominant AI infrastructure player with strong long-term growth prospects, Lumentum currently offers the more compelling investment opportunity. Its explosive AI-driven revenue growth, expanding margins, rapidly scaling optical networking business and strong demand visibility position LITE for superior near-term upside. Despite its premium valuation, Lumentum’s accelerating momentum, higher earnings estimates and AI infrastructure exposure make it the better stock to invest in now.
Currently, LITE sports a Zacks Rank #1 (Strong Buy), while AVGO carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank stocks here.
Revenue surged 90% year over year to $808 million despite management reporting demand exceeding supply by over 30%. Components revenue reached $533 million, growing 20% sequentially and 77% annually as AI optical demand accelerated. Non-GAAP operating margin expanded 2,140 basis points to 32.2%, with Q4 guidance implying further profitability gains.
Air taxi stocks are in the clouds at midday Monday, led by EHang (NASDAQ:EH) stock, which is up 18% to around $7.84. Archer Aviation (NYSE:ACHR | ACHR Price Prediction) shares are rallying 10%, while Joby Aviation (NYSE:JOBY) stock is climbing 7%.
The moves are unfolding against a strong broad-market backdrop. The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is up 1.9% on the session, and the NASDAQ 100 tracking Invesco QQQ Trust (NASDAQ:QQQ) is gaining 3%, with the major indexes pushing near highs.
Here’s the catch for traders following EHang, Archer Aviation, and Joby Aviation: a news scan turned up no fresh company-specific or sector-specific catalyst for the electric vertical takeoff and landing (eVTOL) group today. This appears to be a risk-on bounce in beaten-down, high-beta speculative names amid broad market strength, with the underlying air taxi story unchanged.
Risk-On Bounce, Not a Sector Catalyst Despite the impressive share-price moves today, there’s no identified company-specific or sector-specific catalyst behind today’s eVTOL rally. The apparent driver is a broad risk-on move in equities, with the U.S.-Iran peace deal announced Sunday lifting sentiment across the board.
That setup tends to favor the most speculative names. EHang, Archer Aviation, and Joby Aviation are all pre-commercial or early-revenue businesses, which makes their stocks unusually sensitive to shifts in investor risk appetite.
EHang Leads the Reversal EHang stock is the standout mover, but the bounce comes off a brutal stretch. Shares are down 42% year to date (YTD), and the company carries a market cap near $596 million.
China-based EHang recently reaffirmed FY2026 revenue guidance of about RMB 600 million, and the board approved a $30 million share buyback on June 8. With EHang stock so deeply oversold heading into today, a risk-on session can produce outsized percentage moves on relatively modest flow.
Archer Aviation Bounces Off Lows Archer Aviation stock is rebounding from a difficult stretch as well. ACHR shares are down 26% YTD, even as the company holds roughly $1.8 billion in liquidity and a market cap near $4.28 billion.
Archer Aviation remains a high-profile name in the space, with status as the Official Air Taxi Provider of the LA28 Olympic Games and progress through Phase 3 of FAA Type Certification. None of that is fresh news today, however, which reinforces the read that the move in Archer Aviation stock is market-driven rather than catalyst-driven.
Joby Aviation Posts a More Measured Gain Joby Aviation stock is up a smaller 7% today, which lines up with its more developed financial profile. JOBY shares are down 26% YTD, but the company carries a market cap near $9.66 billion and a stronger revenue base than its eVTOL peers.
Joby Aviation’s most recent quarter, disclosed in SEC filings, showed revenue of $30.84 million against estimates of $16.88 million, and management has guided full-year 2026 revenue to $105 million to $115 million. The company also raised $1.2 billion in February via equity and convertible debt, leaving the balance sheet in a relatively strong spot.
What to Watch Now A key question for EHang, Archer Aviation, and Joby Aviation is whether today’s gains hold into the close. Risk-on bounces in deeply beaten-down names can extend when broad indexes keep grinding higher, but they often fade quickly when the macro tone shifts.
Investors weighing exposure to EHang, Archer Aviation, or Joby Aviation should remember that these are speculative, pre-commercial or early-revenue businesses where share prices can swing sharply in either direction. Sizing one’s positions modestly is one way to participate in the theme without taking on outsized single-name risk.
From here, the next real catalysts are likely to be FAA certification milestones for Archer Aviation, first commercial passenger flights in Dubai for Joby Aviation, and delivery cadence updates from EHang. Until then, sessions like today’s may say more about market mood than about the state of the air taxi business.
A rank-and-file member of Congress earns $174,000 per year. A dividend portfolio can generate the same level of income without a campaign, constituents, or a weekly commute to Washington. Unlike a salary, however, this income is tied to capital, which means the size of the portfolio matters far more than the title attached to the paycheck.
The math is straightforward. Divide the income target by the portfolio yield, and you arrive at the capital required to produce it. Replacing a congressional salary is relatively easy on paper. The more important questions involve the tradeoffs: how much risk you are willing to take, how reliable you need the income to be, and whether that income is likely to grow over time.
Slow and Steady: The 3% to 4% Lane At a 3% yield, replacing the congressional paycheck requires about $5.8 million. At 4%, the figure drops to roughly $4.35 million. This is the territory of dividend aristocrats and broad dividend ETFs.
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) yields 2.3% with 64 consecutive years of increases, most recently raising the quarterly payout to $1.34. Procter & Gamble (NYSE:PG) yields 3% and has paid a dividend every year since 1890. The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) packages a basket of similar names at a 0.06% expense ratio, with top holdings including Bristol-Myers Squibb, Merck, and Chevron.
The tradeoff is straightforward. You need the most capital, but the income stream grows. JNJ’s quarterly dividend has climbed from $0.49 in 2010 to $1.34 today. That is the compounding that defeats inflation.
Where REITs Earn Their Keep: 5% to 7% Capital requirements drop hard here. A 5% yield needs about $3.48 million; a 7% yield needs about $2.49 million. This is REIT and high-dividend equity territory.
Realty Income (NYSE:O) yields 5.4%, pays monthly, and just delivered its 114th consecutive quarterly increase. Portfolio occupancy sits at about 99%, and 2026 AFFO guidance was raised to $4.41 to $4.44. The growth rate is real but modest. Realty Income’s monthly dividend moved from $0.2565 in 2024 to $0.2705 today, a steady drip rather than a curve.
Chasing Double Digits: The 8% to 12% Stretch At 10%, the headline number works: about $1.74 million generates a congressional salary. At 12%, the figure falls to roughly $1.45 million. Business development companies dominate here.
Ares Capital (NASDAQ:ARCC) yields 10.2% on a $1.92 annual distribution, with a weighted average debt yield of 10.3% at amortized cost. Main Street Capital (NYSE:MAIN) pays a $0.26 monthly distribution plus a $0.30 supplemental each quarter.
The catch shows up in the share prices. ARCC trades at roughly 1 times book value, and the stock is down about 6% over the past year. MAIN has slipped roughly 12% year to date. The income arrives. The principal erodes.
Why Dividend Growth Changes the Equation The most important number is not the income a portfolio produces today. It is the income it is likely to produce ten years from now. A portfolio yielding 4% with dividend growth of 7% annually can see its income stream roughly double within a decade without requiring additional capital. By contrast, a portfolio built around a static 10% yield may generate the target income immediately but offer little growth and potentially expose investors to greater principal risk.
Over time, inflation steadily reduces purchasing power. A portfolio that grows its distributions has a better chance of maintaining or increasing real income, while a portfolio that merely maintains its payout may gradually lose ground. For long retirements, income growth can be just as important as starting yield.
The After-Tax Income Advantage Matching a congressional salary on paper is not the same as matching it after taxes. Congressional pay is taxed as ordinary income, while qualified dividends often receive more favorable federal tax treatment. As a result, two investors with identical gross income can end up with very different amounts available to spend.
That distinction also affects portfolio construction. Assets that generate ordinary income, such as many BDCs and REITs, are often more tax-efficient inside retirement accounts. Qualified-dividend payers may be better suited for taxable accounts where investors can benefit from lower tax rates. The result can be a meaningful increase in after-tax income without increasing portfolio risk or changing the overall yield.
Building the Portfolio Calculate your actual spending, not your salary. Per capita disposable income runs $68,359. Most retirees need to replace far less than $174,000. Blend the tiers. A 60/25/15 split across conservative, moderate, and aggressive can land near 5% with real growth. Place ordinary-income payers in tax-advantaged accounts. The 10-year Treasury near 4.5% sets a high bar; your after-tax yield is what matters.
Tripadvisor TRIP shares are climbing following its agreement to sell TheFork to American Express AXP for $700 million in an all-cash deal. This transaction allows TRIP to realize value from a non-core asset while enhancing its balance sheet and capital allocation flexibility. The sale comes after TRIP's decision in February to explore strategic options for TheFork, enabling management to concentrate on its Experiences segment. However, the deal is not expected to finalize until late 2026 and is subject to labor consultations and regulatory approvals.
Asset Value: As of Q1 2026, TheFork reported $232 million in last-twelve-month revenue and an adjusted EBITDA of $28 million, reflecting a valuation of approximately 3.0x revenue and about 25x adjusted EBITDA, which is favorable for a low-margin asset. Tax Treatment: TRIP anticipates that net proceeds will closely match gross proceeds due to minimal tax leakage, enhancing the significance of the $700 million cash influx for potential capital returns or strategic reinvestments. Capital Deployment: Management indicated that the proceeds could be used for share buybacks, debt reduction, or investments in Experiences, with buybacks being the most immediately beneficial option if core performance remains inconsistent. Strategic Reset: This sale allows TRIP to focus on Experiences and Viator, although this segment must demonstrate operational leverage after an 8% revenue increase in Q1, which still resulted in negative adjusted EBITDA. Recent Performance: The sale supports a portfolio simplification strategy in light of disappointing Q1 results, which included an EPS miss and slightly lower revenue, raising concerns about execution in the remaining business. AXP Rationale: For AXP, acquiring TheFork adds over 50,000 restaurants across 11 European countries, expanding its bookable dining network to around 75,000 venues and enhancing its premium dining, travel, and international cardmember ecosystem. Shareholder Pressure: This deal also responds to investor demands to unlock value from non-core assets, particularly from Starboard Value, which had previously advocated for the sale of TheFork. The TRIP/AXP transaction simplifies the narrative from a complex travel portfolio to a streamlined focus on Experiences, Viator, and capital deployment. For TRIP, the monetization of TheFork at a healthy multiple, coupled with minimal tax implications, opens up options for share buybacks, debt reduction, or targeted investments in Experiences. However, this sale alone does not resolve the ongoing challenges in core operations, as the remaining business still needs to achieve consistent revenue, improve margins, and demonstrate that Experiences can scale profitably. For AXP, this acquisition aligns with its strategy to enhance cardmember engagement through dining, travel, and premium lifestyle benefits while expanding its restaurant network and international reach. Key indicators to monitor include TRIP's commitment to shareholder-friendly proceeds utilization, timely transaction closure, and the ability of a more focused portfolio to enhance execution and shareholder value.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
American Express wants to acquire restaurant reservation management platform TheFork from Tripadvisor for $700 million.
Announcing the proposed deal in a Monday (June 15) news release, American Express said it was designed to build on the company’s broader dining strategy following its acquisitions of Resy and Tock.
Put together, the three platforms expand the Amex dining network to 75,000 venues, the company said, citing internal records.
“Dining is one of the most important ways people engage with our brand,” Rafa Marquez, president of international card services at American Express, said in the announcement.
“Over time, the proposed acquisition would help us enrich our differentiated Membership Model by offering Card Members more ways to discover, book and access great restaurants, while helping our partners reach more diners and grow their businesses.”
According to the release, TheFork serves more than 50,000 restaurants in 11 European countries, offering a restaurant management, booking and customer engagement platform, as well as a consumer-facing restaurant discovery and reservation app and website.
Advertisement: Scroll to Continue
“TheFork has built a successful platform across Europe with strong relationships throughout the restaurant industry that would complement our existing capabilities,” Marquez added. “We look forward to supporting TheFork’s continued growth and building on its success as we strengthen our dining presence across Europe.”
American Express in 2024 acquired Tock, a reservation, table and event management technology provider which launched in 2014 was purchased by Squarespace in 2021.
Around the same time, it announced the acquisition of Rooam, which provides mobile payments and ordering technology for restaurants, bars, stadiums and arenas. Those deals followed the company’s acquisition of Resy in 2019.
In other dining news, PYMNTS wrote about the changing restaurant landscape in the wake of COVID and the rise of delivery apps.
While the “scale and convenience of major apps have transformed consumer expectations in ways that are durable,” that report said, the advent of artificial intelligence (AI)-driven commerce solutions could mean restaurants are entering a new era.
“In an agent ordering world, you’re going to be ordering from your TV, from your car, from your phone,” Savneet Singh, CEO of PAR Technology, said in an interview with PYMNTS, noting that those orders can link directly to the restaurant rather than passing through third-party marketplaces.
“That means the restaurant has the data, understands the customer’s preferences, and doesn’t pay a toll to another platform,” Singh added.
UWM Holdings Corporation (“UWMC” or the “Company”) (NYSE: UWMC), today responded to the letter from Two Harbors Investment Corp. (“Two Harbors” or “TWO”) (NYSE: TWO) to its stockholders mischaracterizing discussions between UWMC and TWO that have taken place over the last week, following TWO’s decision to adjourn the special meeting to vote on TWO’s proposed merger with CrossCountry Mortgage, LLC ("CrossCountry" or "CCM") for a third time.
The TWO Board is trying to create the impression of reasonableness while simultaneously inventing arbitrary and self-imposed restrictions that are a ruse and impede the opportunities to get the best result for their stockholders. The bottom line is: the TWO Board is only pretending to engage.
UWMC believes the TWO Board has mischaracterized the interactions between TWO and UWMC to try and convince stockholders that their only option is to accept the inferior CCM transaction, but stockholders deserve to know that this could not be further from the truth, including due to the following facts:
The TWO Board created an arbitrary five-day limit on their ability to engage in discussions with UWMC, an intentionally unreasonable time period to finalize an agreement or a revised proposal based on an alternative structure. The TWO Board restricted who from UWMC could take part in negotiations, “summoned” our CEO to New York on short notice and declined an open invitation to come to Michigan. TWO refused to provide updated financial information upon which UWMC could prepare a revised proposal. Instead, TWO questioned whether the parties were under NDA and indicated it would only provide updated financials if UWMC submitted a revised written proposal. UWMC offered multiple alternative consideration structures to address TWO’s concerns, including adjustments to the default election to cash or providing a “higher of cash or stock” consideration for the stockholders whom TWO is concerned will not make an affirmative selection. The TWO Board categorically ruled out any form of stock as part of the merger consideration, even though it is an added and optional bonus to stockholders, irrespective of the total value to be conveyed and regardless of stockholders’ already agreed and unfettered ability to make an election to receive cash. Even under UWMC’s current proposal (before any modifications) all TWO stockholders would receive at the closing the stock consideration which may appreciate significantly between now and then (thus a free “call option”) or, if closer to closing they so elect, cash at $12.50 per share, thus also a valuable put option in itself. The existence of such optionality provides more value, not less, as the TWO Board and its financial advisors should know. The only group that would not receive that optionality with respect to their benefits package is TWO management; this is the only logical explanation for their unwillingness to accept any stock consideration whatsoever or truly engage and declare our offer “potentially superior.” Even after three delays of the special meeting, TWO’s Board refuses to listen to TWO’s stockholders, who have rejected the CCM deal and the adjournments three times already. Despite our significant concerns, UWMC remains committed to pursuing a transaction with TWO and is ready to engage in open, unrestricted, good faith discussions, provided the TWO Board acts solely to achieve the best result for its stockholders. UWMC is also prepared to continue discussing enhancements to its proposed terms, including alternatives around the default election mechanism or other adjustments to the merger consideration that we suggested to TWO in our meeting and TWO flatly rejected upfront despite UWMC offering modifications to an already superior offer.
To be clear, our goal is to reach a transaction that is best for UWMC and for TWO stockholders, and we have been investing considerable time and resources over the last several months in this effort. If TWO will engage in true good faith discussions, there is no reason we cannot reach an agreement quickly.
Make no mistake: the TWO Board knows how to conclude that a proposal would be reasonably expected to result in a superior proposal and how to truly engage – they did it previously while under contract with UWMC. Why can’t the TWO Board follow the same process now and commence a true process with us?
The only way for the TWO stockholders to cause their Board to do the right thing and achieve higher value for them is to continue to keep the pressure on their Board and vote AGAINST the CCM deal on June 23. We encourage all TWO stockholders to vote AGAINST the transaction on UWMC’s BLUE proxy card to reject the flawed and value-minimizing process of the TWO Board.
How to Vote
UWMC reaffirms its recommendation that TWO stockholders should vote AGAINST the proposed CCM transaction on UWMC’s BLUE proxy card and urge the TWO Board to engage with UWMC as its best path to maximize value for TWO stockholders.
UWMC encourages all TWO stockholders to review its definitive proxy statement on file with the SEC for more detail about why voting AGAINST the CCM transaction helps maximize value for stockholders.
We urge all TWO stockholders toVOTE AGAINST Two Harbors’ CCM Merger Proposal, AGAINST the Non-Binding Compensation Advisory Proposal and AGAINST the Adjournment Proposal according to the instructions on UWMC’s BLUE Proxy Card today to preserve the opportunity to achieve greater value by engaging with UWMC’s superior proposal.
If you have any questions or require assistance with voting your shares, please contact our proxy solicitor, Okapi Partners, by calling (844) 343-2621 (Toll Free for stockholders) or (212) 297-0720 (For Banks and Brokers), or by email at [email protected].
VOTE AGAINST THE PROPOSED CCM MERGER ON THE BLUE PROXY CARD TODAY!
YOUR VOTE IS IMPORTANT, NO MATTER HOW MANY SHARES YOU OWN!
About UWM Holdings Corporation and United Wholesale Mortgage
Headquartered in Pontiac, Michigan, UWM Holdings Corporation (UWMC) is the publicly traded indirect parent of United Wholesale Mortgage, LLC (“UWM”). UWM is the nation’s largest home mortgage lender, despite exclusively originating mortgage loans through the wholesale channel. UWM has been the largest wholesale mortgage lender for 11 consecutive years and is also the largest purchase lender in the nation. With a culture of continuous innovation of technology and enhanced client experience, UWM leads the market by building upon its proprietary and exclusively licensed technology platforms, superior service and focused partnership with the independent mortgage broker community. UWM originates primarily conforming and government loans across all 50 states and the District of Columbia. For more information, visit uwm.com or call 800-981-8898. NMLS #3038.
This communication includes forward-looking statements. These forward-looking statements are generally identified using words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict” and similar words indicating that these reflect our views with respect to future events. Forward-looking statements in this communication include statements regarding our expectations and beliefs related to (i) the timing of the completion of any proposed transaction; (ii) the ability of the parties to complete any proposed transaction; and (iii) the benefits of a proposed transaction. These statements are based on management’s current expectations, but are subject to risks and uncertainties, many of which are outside of our control, and could cause future events or results to materially differ from those stated or implied in the forward-looking statements, including: (i) that the parties will not agree to pursue a business combination transaction or that the terms of any such transaction will be materially different from those described herein; (ii) the ability of the parties to satisfy the conditions to any proposed transaction, including obtaining stockholder approval and regulatory approval, on a timely basis or at all; (iii) the ability to obtain synergies and benefits of any proposed transaction; (iv) UWM’s ability to successfully implement strategic decisions and product launches; (v) UWM’s dependence on macroeconomic and U.S. residential real estate market conditions, including changes in U.S. monetary policies, more specifically caused by the Presidential Administration that affect interest rates and inflation; (vi) UWM’s reliance on its warehouse and MSR facilities and the risk of a decrease in the value of the collateral underlying certain of its facilities causing an unanticipated margin call; (vii) UWM’s ability to sell loans in the secondary market; (viii) UWM’s dependence on the government-sponsored entities such as Fannie Mae and Freddie Mac; (ix) changes in the GSEs, FHA, USDA and VA guidelines or GSE and Ginnie Mae guarantees; (x) our ability to consummate the merger with Two Harbors and achieve the anticipated benefits; (xi) our ability to comply with all rules and regulations in connection with the launch of our internal servicing and the new risks that may be presented as a result of the transition; (xii) UWM’s dependence on Independent Mortgage Advisors to originate mortgage loans; (xiii) the risk that an increase in the value of the MBS UWM sells in forward markets to hedge its pipeline may result in an unanticipated margin call; (xiv) UWM’s inability to continue to grow, or to effectively manage the growth of its loan origination volume; (xv) UWM’s ability to continue to attract and retain its broker relationships; (xvi) UWM’s ability to implement technological innovation, such as AI in our operations; (xvii) the occurrence of a data breach or other failure of UWM’s cybersecurity or information security systems; (xviii) reliance on third-party software and services; the occurrence of data breaches or other cybersecurity failures at our third-party sub-servicers or other third-party vendors; (xix) UWM’s ability to continue to comply with the complex state and federal laws, regulations or practices applicable to mortgage loan origination and servicing in general; and (xx) other risks and uncertainties indicated from time to time in our filings with the Securities and Exchange Commission (the “SEC”) including those under “Risk Factors” therein. We wish to caution readers that certain important factors may have affected and could in the future affect our results and could cause actual results for subsequent periods to differ materially from those expressed in any forward-looking statement made by or on behalf of us. We undertake no obligation to update forward-looking statements to reflect events or circumstances after the date hereof.
No Offer or Solicitation
This communication is for informational purposes only and is not intended to, and shall not, constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
Additional Information
This communication relates to a proposal that UWMC has made to the Two Harbors Board for a business combination transaction with Two Harbors. In furtherance of this proposal and subject to future developments, UWMC filed a definitive proxy statement on Schedule 14A on May 14, 2026 (the “Proxy Statement”) with the SEC in order to solicit proxies against the Proposed CCM Merger and other proposals to be voted on by TWO stockholders at the special meeting of TWO stockholders to be held to approve the Proposed CCM Merger. UWMC may file amendments or supplements to the Proxy Statement and one or more registration statements, proxy statements, tender or exchange offers or other documents with the SEC. This communication is not a substitute for any proxy statement, registration statement, tender or exchange offer document, prospectus or other document UWMC and/or Two Harbors may file with the SEC in connection with a proposed transaction.
INVESTORS AND SECURITYHOLDERS OF UWMC AND TWO HARBORS ARE URGED TO READ THE PROXY STATEMENT, ANY ADDITIONAL MATERIALS UWMC MAY FILE WITH RESPECT TO THE BUSINESS COMBINATION TRANSACTION, INCLUDING ANY REGISTRATION STATEMENT, TENDER OR EXCHANGE OFFER DOCUMENT, PROSPECTUS, AND ANY OTHER RELEVANT DOCUMENTS IF AND WHEN FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY, WHEN THEY ARE AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT UWMC, TWO HARBORS, A PROPOSED TRANSACTION AND RELATED MATTERS. Investors and securityholders of UWMC and Two Harbors will be able to obtain copies of these documents if and when they become available, as well as other filings with the SEC that will be incorporated by reference into such documents, containing information about UWMC and Two Harbors, without charge, at the SEC’s website (http://www.sec.gov). Copies of the documents filed with the SEC by UWMC will be available free of charge under the SEC Filings heading of the Investor Relations section of UWMC’s website at https://investors.uwm.com.
Participants in the Solicitation
UWMC and its respective directors and executive officers and other members of management and employees may be deemed to be participants in any solicitation of proxies from Two Harbors stockholders in respect of a solicitation and proposed transaction under the rules of the SEC. Information regarding UWMC’s directors and executive officers is available in UWMC’s Annual Report on Form 10-K for the year ended December 31, 2025, and UWMC’s proxy statement, dated April 24, 2026, for its 2026 annual meeting of stockholders (the “UWMC 2026 Proxy”), which can be obtained free of charge through the website maintained by the SEC at http://www.sec.gov. Please refer to the sections captioned “Compensation Discussion and Analysis”, “Executive Compensation”, “Stock Ownership” and “Proposal 3 – Advisory Vote on Executive Officer Compensation” in the UWMC 2026 Proxy. Any changes in the holdings of UWMC’s securities by UWMC’s directors or executive officers from the amounts described in the UWMC 2026 Proxy have been reflected in Statements of Change in Ownership on Form 4 filed with the SEC subsequent to the filing date of the UWMC 2026 Proxy and are available at the SEC’s website at www.sec.gov.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260615261665/en/
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
The proposed transactions may contain terms that could limit superior competing offers.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Dana Incorporated (NYSE: DAN)’s sale to Eaton Corporation plc. Upon closing of the Proposed Transaction, Dana shareholders will own approximately 49.9% of the combined company. If you are a Dana shareholder, click here to learn more about your legal rights and options.
Nuvalent, Inc. (NASDAQ: NUVL)’s sale to GSK plc for $124.00 per share in cash. If you are a Nuvalent shareholder, click here to learn more about your rights and options.
SUNation Energy, Inc. (NASDAQ: SUNE)’s merger with Suniva. Upon closing of the proposed transaction, SUNation shareholders are expected to own approximately 1.8% of the combined company. If you are a SUNation shareholder, click here to learn more about your rights and options.
Taylor Morrison Home Corporation (NYSE: TMHC)’s sale to Berkshire Hathaway Inc. for $72.50 per common share in cash. If you are a Taylor Morrison shareholder, click here to learn more about your legal rights and options.
On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060 [email protected] [email protected]
https://www.halpersadeh.com
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.
First Financial Bancorp (FFBC - Free Report) is headquartered in Cincinnati, and is in the Finance sector. The stock has seen a price change of 29.1% since the start of the year. The holding company for First Financial Bank is currently shelling out a dividend of $0.25 per share, with a dividend yield of 3.1%. This compares to the Banks - Midwest industry's yield of 2.59% and the S&P 500's yield of 1.41%.
Looking at dividend growth, the company's current annualized dividend of $1.00 is up 2% from last year. Over the last 5 years, First Financial Bancorp has increased its dividend 1 times on a year-over-year basis for an average annual increase of 0.82%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. First Financial's current payout ratio is 33%, meaning it paid out 33% of its trailing 12-month EPS as dividend.
FFBC is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2026 is $3.20 per share, representing a year-over-year earnings growth rate of 9.22%.
Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. However, not all companies offer a quarterly payout.
For instance, it's a rare occurrence when a tech start-up or big growth business offers its shareholders a dividend. It's more common to see larger companies with more established profits give out dividends. During periods of rising interest rates, income investors must be mindful that high-yielding stocks tend to struggle. That said, they can take comfort from the fact that FFBC is not only an attractive dividend play, but also represents a compelling investment opportunity with a Zacks Rank of #2 (Buy).
Wiley (NYSE: WLY) and IQVIA (NYSE: IQV) today released Scientific Discovery & AI: The Science-to-Patient Journey, a cross-sector intelligence report drawing on candid dialogue among more than 25 senior leaders from pharma R&D, academic medicine, health systems, AI and technology, publishing and learned societies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615344569/en/
The report summarizes insights from The Summit — an invitation-only, two-day working session co-hosted by Wiley and IQVIA in May 2026. The session opened with a forward-looking perspective on AI and organizational change from Ethan Mollick, Wharton professor, NYT bestselling author of Co-Intelligence, and the forthcoming Co-Existence (October 2026), which set the tone for the dynamic days of discussion. Participants included senior leaders from organizations such as Novo Nordisk, Microsoft, Amazon, Salesforce, American Association for the Advancement of Science (AAAS), American Heart Association, JAMA Network, Johns Hopkins University, University of Michigan, Mapúa University, South Dakota State University, American Society of Mechanical Engineers (ASME), BMJ Group, Japan Advanced Institute of Science and Technology, Queen Mary Intellectual Property Research Institute and Turbine.
A key focus of the report is the gap between AI's technical capability and the health system's ability to absorb it. AI is accelerating every stage of the journey from scientific discovery to patient benefit — but acceleration at one stage can create fracture at the next. Examining each stage of the science-to-patient value chain, participants identified five high-potential directions for the ecosystem:
Decision-first discovery: Embracing AI for large-scale exploration to support wet lab target identification and validation. Structured negative data: Sharing vetted failed experiments to avoid unnecessary repetition. AI agents for patients: Deploying patient-facing AI to help them navigate health systems. Curated aggregation: Combining the scholarly record and real-world data as a trusted alternative to general-purpose AI search. Continuous learning loop: Feeding real-world evidence back into trial design, clinical guidelines and upstream research. “For AI to deliver its full promise in healthcare and science, all parts of the system must be engaged. AI has vastly increased the speed at which we can resolve molecular identities and surface new candidates — but if the publishing model, clinical development infrastructure and real-world adoption don’t keep pace, those discoveries won’t reach patients as quickly as they should,” said Armughan Rafat, Wiley SVP, Chief AI & Data Analytics Officer. “That’s the conversation Wiley and IQVIA have convened. We didn’t set out to produce consensus, but rather to surface an honest diagnosis.”
"AI is already reshaping every stage of the healthcare value chain, but the real opportunity lies in connecting those stages into a continuous learning system. What emerged from The Summit is a clear need to move beyond isolated innovation toward integrated evidence ecosystems – where clinical research, real-world data and advanced analytics work in unison. By closing the loop between discovery, development and real-world outcomes, we can accelerate not just insight generation, but meaningful impact for patients," said Rob Kotchie, IQVIA President, Real World Evidence & Clinical Technology Solutions.
The report is also candid about identifying existing structural limits. A consistent finding across every stage of the value chain is that incentives are an impediment: the system rewards behaviors that don’t always optimize for science, patients or long-term progress. Addressing such misalignment requires collaboration across actors and structural change.
Scientific Discovery & AI: The Science-to-Patient Journey is available now at this link. The reportmaps the findings from The Summit across four stages of the science-to-patient value chain: Discovery & Early Research, Clinical Development & Evidence Generation, Validation & Dissemination and Real-World Adoption & Patient Impact.
Together, Wiley and IQVIA span the full value chain — from evidence creation and peer review through real-world clinical application — and are strongly positioned to connect the stakeholders who need to be in conversation.
About Wiley
Wiley (NYSE: WLY) is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.
About IQVIA
IQVIA NYSE:IQV is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 93,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
Category: All Corporate News
View source version on businesswire.com: https://www.businesswire.com/news/home/20260615344569/en/
ATLANTA, June 15, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) complied with federal securities laws. On June 8, 2026, Hunterbrook Media published a report alleging, among other things, that “Ensign’s profits can be traced to providing less care than its patients need — and less care than it is meant to provide based on the tax dollars it receives from the government.” The price of the Company’s stock dropped following this news.
If you purchased Ensign stock and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at [email protected] or Joshua Karr, Esq. at [email protected], call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/the-ensign-group/ to discuss your legal rights.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (NASDAQ: CHX) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ChampionX securities between February 29, 2024 and April 1, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/CHX.
ChampionX Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
(1)while repurchasing millions of dollars’ worth of ChampionX Corporation (“ChampionX” or the “Company”) common stock, Defendants were in possession of material nonpublic information regarding offers made by Schlumberger Limited (“SLB”) to acquire ChampionX at a premium to prevailing market prices; (2)Defendants failed to either abstain from trading or disclose SLB’s offer(s), which, if disclosed, would have signaled to investors that ChampionX’s stock was worth significantly more than its trading price; (3)Defendants further failed to disclose subsequent offers and negotiations involving ChampionX and SLB; and (4)as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading at all relevant times.
What's Next for ChampionX Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/CHX. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in ChampionX you have until July 14, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to ChampionX Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for ChampionX Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In PicS To Contact Him Directly To Discuss Their Options
If you purchased or acquired PicS Class A Common stock in and/or traceable to PicS' January 30, 2026 initial public offering ("IPO") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - June 15, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PicS N.V. ("PicS" or the "Company") (NASDAQ: PICS) and reminds investors of the August 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) PicS N.V. had conducted an evaluation of its credit evaluation procedures in December 2025 and determined that such procedures were deficient and in need of enhancement; (2) as a result of the new procedures PicS N.V. had implemented in December 2025, PicS N.V. had reclassified approximately R$590 million of exposures previously classified as Stage 2 to Stage 3, leading to an incremental ECL charge of R$88 million in the three months ended December 31, 2025; (3) PicS N.V. had experienced a heightened, but unreported, Stage 3 formation rate of more than 7% in the fourth quarter of 2025 that deviated substantially from the historical results and trends provided in the offering documents; (4) the IPO's offering documents had materially overstated the quality and ability of PicS N.V.'s credit models and user data to inform PicS N.V.'s underwriting practices and to allow PicS N.V. to timely and effectively monitor, assess, and identify adverse credit events, credit risks, and credit deterioration across its portfolio; and (5) PicS N.V. suffered from degradations in customer credit quality and heightened risks of default and loan impairment as a result of its entrance into materially riskier business lines leading up to the IPO, resulting in undisclosed adverse financial and operational trends such as heightened incidents of default, which predated the IPO and were internally projected by PicS N.V. to continue to worsen following the IPO, materially impairing PicS N.V.'s business, operations, and financial results.
On or around January 29, 2026, PicPay conducted its initial public offering ("IPO"), selling 22.86 million Class A common shares priced at $19.00 per share.
Then, on March 18, 2026, PicPay released its fourth quarter 2025 financial results and revealed that, as part of the Company's "annual review of expected credit loss parameters," it had made several "enhancements" to its Expected Credit Loss ("ECL") calculations, and "implemented a stricter policy to accelerate the classification of renegotiated non-performing exposures from Stage 2 to Stage 3." Consequently, "R$590 million of Stage 2 portfolio balances were reclassified to Stage 3, resulting in an ECL increase of R$88 [$17.56 million USD]." Stage 3 is the Company's highest risk category for its credit portfolio.
On this news, PicPay's stock price fell $3.56 per share, or 22.5%, to close at $12.27 per share on March 19, 2026.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding PicS' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the PicS N.V. class action, go to www.faruqilaw.com/PICS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the PicS N.V. Securities Class Action Lawsuit:
What is the PicS N.V. securities fraud lawsuit about?
The PicS N.V. securities fraud lawsuit is a federal securities class action alleging that PicS N.V. (NASDAQ: PICS) and its executives made false and misleading statements to investors in connection with the Company's January 30, 2026 IPO by concealing that the Company had already identified deficiencies in its credit evaluation procedures in December 2025, had reclassified approximately R$590 million of exposures from Stage 2 to Stage 3 (its highest credit risk category) resulting in an incremental expected credit loss charge of R$88 million, and was experiencing a Stage 3 formation rate exceeding 7% in Q4 2025 - a significant deviation from the historical trends presented in the IPO's offering documents. As the truth emerged on March 18, 2026, when PicS disclosed these credit portfolio deteriorations as part of its Q4 2025 financial results, PICS shares fell $3.56 per share, or 22.5%, to close at $12.27 - well below the $19.00 IPO price - causing significant losses for investors.
Who may be eligible to participate in the PicS N.V. class action lawsuit?
Investors who purchased PicS N.V. (PICS) Class A common stock in and/or traceable to the Company's January 30, 2026 initial public offering and suffered financial losses may be eligible to participate in the PicS securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former PicS employees, and others with relevant information about the Company's conduct are also encouraged to come forward.
What is a lead plaintiff, and how can I seek appointment in the PicS N.V. lawsuit?
A lead plaintiff in the PicS N.V. class action is a court-appointed investor - typically the one with the largest financial interest in the case - who directs and oversees the litigation on behalf of all class members. Any PicS investor who purchased PICS Class A common stock in or traceable to the IPO may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is August 4, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.
What should investors do if they purchased PicS N.V. stock in the IPO?
Investors who purchased PicS N.V. (PICS) Class A common stock in and/or traceable to the January 30, 2026 IPO and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the PicS N.V. securities class action is August 4, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/PICS for more information.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301508
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Commvault To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Commvault between April 29, 2025 and January 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - June 15, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Commvault Systems, Inc. ("Commvault" or the "Company") (NASDAQ: CVLT) and reminds investors of the July 17, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
Defendants provided investors with material information pertaining to Commvault's projected ARR growth for fiscal year 2026. Defendants' statements included, among other things, misleading guidance and projections related to the Company's new net ARR growth. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Commvault's ARR growth environment; pertinently, Commvault knew or recklessly disregarded that the Company's ARR growth guidance failed to properly factor in crucial variables, such as the type of sale. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Commvault's securities at artificially inflated prices.
On January 27, 2026, Commvault reported financial results for the third quarter of fiscal 2026 ended December 31, 2025, including "40% growth in SaaS ARR to $364 million," as noted by the Company's Chief Accounting Officer ("CAO") during the earnings call to discuss these results. Additionally, the CAO said "60% of our deals actually closed in the last few weeks of the quarter." According to Bloomberg Intelligence, "SaaS ARR growth of 40% represents a meaningful deceleration from 56%" reported for the second quarter fiscal 2026.
Following this news, Commvault stock declined over 31% on January 27, 2026.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Commvault's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Commvault class action, go to www.faruqilaw.com/CVLT or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the Commvault Systems Securities Class Action Lawsuit:
What is the Commvault Systems securities fraud lawsuit about?
The Commvault Systems securities fraud lawsuit is a federal securities class action alleging that Commvault Systems, Inc. (NASDAQ: CVLT) and its executives made false and misleading statements to investors by providing materially misleading guidance and projections related to the Company's annual recurring revenue (ARR) growth while concealing that its ARR growth guidance failed to properly account for crucial variables - such as the type of sale - that significantly affected the Company's true growth trajectory. As the truth emerged on January 27, 2026, when Commvault reported Q3 fiscal 2026 results showing SaaS ARR growth of only 40% - a meaningful deceleration from 56% in the prior quarter - CVLT's stock price fell over 31% in a single day, causing significant losses for investors.
Who may be eligible to participate in the Commvault Systems class action lawsuit?
Investors who purchased or acquired Commvault Systems (CVLT) stock between April 29, 2025 and January 26, 2026 - the Class Period - and suffered financial losses may be eligible to participate in the Commvault securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former Commvault employees, and others with relevant information about the Company's conduct are also encouraged to come forward.
What is a lead plaintiff, and how can I seek appointment in the Commvault Systems lawsuit?
A lead plaintiff in the Commvault Systems class action is a court-appointed investor - typically the one with the largest financial interest in the case - who directs and oversees the litigation on behalf of all class members. Any Commvault investor who purchased CVLT stock during the Class Period may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is July 17, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.
What should investors do if they purchased Commvault Systems stock during the Class Period?
Investors who purchased Commvault Systems (CVLT) stock between April 29, 2025 and January 26, 2026 and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the Commvault Systems securities class action is July 17, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/CVLT for more information.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301500
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ServBanc Holdco, Inc. (“ServBanc Holdco”), as successor in interest to IF Bancorp, Inc. (“IF Bancorp” or the “Company”) (NASDAQ: IROQ), the members of IF Bancorp’s board of directors (the “Board”), and ServBank, National Association (“ServBank, N.A.”).
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws. The claims arise in connection with the Board’s solicitation of IF Bancorp shareholders to vote in favor of a merger transaction (the “Merger”)—based on false representations of the consideration shareholders would receive—pursuant to which IF Bancorp merge with and into ServBanc Holdco. Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/IROQ.
ServBanc Case Details
The Complaint alleges that, in connection with IF Bancorp’s merger with ServBanc Holdco, Defendants caused the Company to issue a materially false and misleading proxy statement that, among other things:
(1) overstated the value and likelihood of the consideration to be received by shareholders, including a purported $27.20 per-share merger price and the possibility of a special dividend tied to certain tangible common equity thresholds;
(2) failed to disclose that, due to a required $13.99 million loan renewal and an associated reserve that would be imposed as a condition of ServBanc Holdco’s approval, there was no meaningful likelihood that IF Bancorp’s tangible common equity would meet the threshold necessary to avoid a downward adjustment or to trigger any special dividend;
(3) misled shareholders regarding the true amount and likelihood of the consideration they would receive, when in reality the merger consideration was expected to be reduced to approximately $26.40 per share and any additional contingent payment was uncertain and dependent on future loan repayment; and
(4) as a result, Defendants’ statements were materially false and misleading at all relevant times, depriving shareholders of the ability to cast a fully informed vote, inducing them to approve the Merger and forgo appraisal rights, and causing them to receive less than the fair value of their shares.
What's Next for ServBanc Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/IROQ. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you held shares as of February 3, 2026, you have until June 29, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to ServBanc Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for ServBanc Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
